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Various species of mosquitoes from the genus Anopheles vector the Plasmodium spp. 
parasites responsible for human malaria. While traditional, drug and insecticide based, 
efforts to control malaria have met with some success in limited geographic areas, there 
are still millions of cases each year and novel control strategies are needed to effect 
permanent reductions on a worldwide scale. One potential method to control malaria is to 
harness the mosquito immune system to create mosquitoes refractory to Plasmodium 
infection via genetic engineering. Efforts to create such mosquitoes have succeeded in 
multiple laboratories, but no such mosquitoes have been released as part of a large-scale 
malaria control program, partly due to a lack of knowledge about their biology. We 
undertook to expand our knowledge of the effects of genetic modification on An. 
stephensi mosquitoes. First, we characterized the transcriptomic and proteomic effects of 
transient up-regulation of the IMD pathway associated NF-kB transcription factor Rel2, 
showing that a very large number of both immune and non-immune genes are controlled 
by this up-regulation, and allowing us to identify novel anti-Plasmodium factors in the 
mosquito.  We then measured the fitness of 5 genetically modified An. stephensi strains 
under a variety of conditions and using varied measures. These data showed that, while 
some genetically modified mosquitoes do bear a fitness cost due to the genetic 
modification, there is no inherent fitness cost to transgenesis. This indicates that 
genetically modified mosquitoes are a viable tool for malaria control and further efforts 
should pursue the testing of these mosquitoes on a larger scale in order to prepare them 
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Chapter 1: Introduction 
(Modified from  Pike, A., C. Cirimotich, and G. Dimopoulos. 2013. Impact of Transgenic 
Immune Deployment on Mosquito Fitness. In W. Takken and C. J. Koenraadt [eds.], 
Ecology of Parasite-Vector Interactions.Wageningen Academic Publishers, Wageningen) 
 
1.1 Introduction 
 Mosquitoes vector a variety of important human pathogens including viruses, 
filaria and apicomplexan parasites.  Mosquitoes acquire these infections while taking a 
blood meal necessary for reproduction, and pass them on when they take subsequent 
blood meals. While traditional vector-control methods have been used to control these 
diseases for many years, they have yet to make lasting inroads in the battle to eliminate 
diseases such as malaria and dengue fever.  Tools such as insecticides, bed nets and larval 
source management are able to reduce infections in an area temporarily; however, 
constant application of these mosquito control methods is necessary, as the diseases 
rebound soon after control measures are removed (Smith et al. 2013a). Due to this, in 
order for permanent removal of vector-borne diseases to be achieved, new technologies 
must be developed that can effect lasting change in vector populations or behaviors and 
eliminate the diseases.  
 A variety of factors contribute to the ability of a mosquito to transmit a pathogen 
successfully and to the efficiency of disease transmission, referred to as the vectorial 
capacity. The inherent capability of a mosquito to transmit the pathogen, or vector 
competence, is determined by genetic components of the mosquito and pathogen as well 
as by environmental components, including temperature. Other variables involved in 
vectorial capacity include the vector population density, the extrinsic incubation period 
required for vectors to become infectious and the daily survival rate of competent vectors. 
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A mathematical model of vectorial capacity was first described by Ross (Ross 1911) and 
later refined by Macdonald (Macdonald 1957) and Smith and MacKenzie (Smith and 
McKenzie 2004).  The full equation is given by  
      
    
, where C is the vectorial 
capacity, β is the vector competence, a is the daily biting rate, n is the extrinsic 
incubation period of the pathogen and p is the daily survival rate.  A change in any one of 
these variables can greatly affect the overall vectorial capacity for a specific pathogen 
and alter the persistence of the disease. 
 The advent of molecular biology, genomics and functional genomics has provided 
unprecedented opportunities to elucidate the complex interactions that take place between 
the mosquito vector and the pathogens it transmits. This new technology has led to 
significant advances in our understanding of how the mosquito’s innate immune system 
is actively involved in eliminating large fractions of these human pathogens, sometimes 
rendering the mosquito vector completely refractory to infection (Garver et al. 2009). The 
progress made in basic research, together with the development of mosquito transgenic 
methodologies, has opened the way for the development of novel disease control 
strategies that are based on blocking pathogen transmission in genetically modified 
super-immune mosquitoes (Dong et al. 2011). However, despite the ongoing 
development of powerful genetic drive systems, a potential bottleneck in the course of 
successful deployment of genetically modified pathogen-immune mosquitoes is the 
possible impact of the immune transgene on mosquito fitness.  
 Two main mosquito populations have been targeted for genetic modification. The 
yellow fever mosquito, Aedes aegypti, is the main vector for urban dengue fever. With a 
wide geographic range, this mosquito, along with the closely related Ae. albopictus, 
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spread dengue virus and various other viruses to people around the world (WHO 2014a). 
Due to its preference for living in urban areas and biting humans, Ae. aegypti is an 
efficient vector of dengue virus and leads to large numbers of infections each year. While 
Ae. albopictus also acts as a vector for dengue virus, Ae. aegypti is considered the main 
vector of the disease and is likely responsible for the majority of the 50-100 million cases 
each year from dengue virus (WHO 2014a). The mosquito has also been moving around 
the world rapidly due to human movement, leading to the possibility of this disease 
traveling to new geographic areas or returning to places after the disease has been 
removed, as new vector populations can become established and start spreading the 
disease (Brown et al. 2014).  Genetic modification of Ae. aegypti has occurred in multiple 
laboratories with the intent of using these mosquitoes to reduce dengue associated 
morbidity and mortality, and field trials with some of these strains are now underway 
(Bian et al. 2005, Franz et al. 2006). 
 Anopheles spp. mosquitoes have also been genetically modified in multiple 
laboratories (Ito et al. 2002, Dong et al. 2011, Isaacs et al. 2012).  Various anopheline 
mosquitoes are the vectors for the Plasmodium spp. parasites responsible for human 
malaria, though the specific mosquito species responsible for transmission varies from 
area to area. Malaria causes upwards of 200 million cases and 650,000 deaths each year 
world-wide, largely among African children, and has been called the most important 
vector-borne disease affecting man (WHO 2014b).  There have been many efforts over 
the years to curb malaria's death toll, however none has been able to cause a significant 
reduction in the hardest hit areas.  While effective drugs to treat malaria cases exist, an 
effective vaccine has not yet been licensed and vector control through bednets and indoor 
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residual spraying remain the front line of defense against the disease.  Therefore, genetic 
modification of anopheline mosquitoes may form an important and component of future 
malaria control programs. Two important species that have been well studied in the 
laboratory, have had their genomes sequenced and have been genetically modified in the 
laboratory successfully are An. gambiae, the primary malaria vector in much of Sub-
Saharan Africa, and An. stephensi, an urban malaria vector from the Indian subcontinent 
(Holt et al. 2002, Jiang et al. 2014).  While not as universal in their distribution and 
worldwide importance as malaria vectors as Ae. aegypti is for dengue virus, these two 
species are good representatives of the tribe and are a good pair to start with for proving 
the viability of using genetically modified mosquitoes to control malaria. 
 Despite the availability of tools to make genetically modified mosquitoes and 
multiple laboratories capable of doing that, no such tools have yet been used as part of a 
worldwide dengue or malaria control program. This stems from a variety of issues 
including differing views of how to use genetically modified mosquitoes to reduce 
disease incidence, potential negative fitness effects of genetic modification, public 
perception of genetically modified organisms as a whole and difficulties determining the 
necessary number of mosquitoes to release and the ability to produce those mosquitoes.  
 
1.2 The mosquito innate immune system 
 Infection of a mosquito with a virus or parasite has a profound effect on the 
transcriptional repertoire of the mosquito. Hundreds of genes are regulated and 
implicated during infection, especially those encoding factors involved in the mosquito 
innate immune response (Dong et al. 2006b, Xi et al. 2008b). Mosquito genetics play a 
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crucial role in vector competence, and especially in the inherent ability of the mosquito to 
mount an effective neutralizing immune response against the invading pathogen. Unlike 
humans and other mammals, mosquitoes do not have genes for the production of 
antibodies and other molecules of the adaptive immune response. Instead, the mosquito’s 
innate immune system directly responds to and combats pathogens upon challenge. 
Pattern recognition receptors (PRRs) on the surface of immune-competent cells or 
circulating in the hemolymph bind to specific pathogen-associated molecular patterns 
(PAMPs), triggering a series of reactions that culminate in the expression of anti-
pathogen effector molecules. The ultimate result of immune pathway activation is an up-
regulation of specific gene expression that is PAMP- and pathway-dependent. These 
immune effector genes form an important line of defense for the mosquito against a 
variety of invading pathogens.  PRRs can also directly activate immune defense 
mechanisms such as phagocytosis and complement-like killing mechanisms, independent 
of the intracellular immune signaling pathways. 
 Various cellular and humoral factors in the mosquito hemolymph play a 
significant role in the response to microbial challenge. Circulating immune-competent 
cells, known as hemocytes, phagocytose and encapsulate foreign particles and pathogens. 
Simultaneously, serine protease cascades activate enzymes that generate melanin and free 
radicals, which are responsible for killing microbes during humoral responses.  These 
effectors create a series of barriers that a pathogen must surmount before the mosquito 
becomes infectious, and an increase in any of these anti-pathogen factors can greatly 
reduce the vector competence of the mosquito. 
6 
 
 A number of immune signaling pathways regulate anti-pathogen immunity in 
mosquitoes.  With the advent of whole-genome sequencing projects over the past decade 
(Holt et al. 2002, Nene et al. 2007, Jiang et al. 2014), the three major immune signaling 
pathways (Toll, IMD, and Jak/Stat) that were originally described in Drosophila or 
mammals have been identified through orthology in mosquitoes (Christophides et al. 
2002).  
 The Toll pathway has been implicated in the mosquito defense against fungal, 
bacterial, parasitic and viral infections (Shin et al. 2005, Xi et al. 2008b, Antonova et al. 
2009). PAMP recognition by Toll pathway PRRs is well documented, but the underlying 
mechanism is still unresolved. The Drosophila genome encodes two distinct Toll 
pathway-regulated transcription factors, Dif and Dorsal, which mediate immune and 
developmental gene expression, respectively.  The Ae. aegypti genome also encodes two 
distinct Toll pathway transcription factors (REL1A and REL1B), while the An. gambiae 
genome encodes a single factor (REL1/GAMBIF1) (Barillas-Mury et al. 1996, Shin et al. 
2002). 
 It has been shown through transient activation of the Toll pathway via silencing of 
the negative regulator cactus that Rel1-transcribed effector molecules are critical for the 
Ae. aegypti defense against dengue viruses (Xi et al. 2008b, Ramirez and Dimopoulos 
2010) and the An. gambiae defense against rodent malaria parasites (Meister et al. 2005, 
Frolet et al. 2006, Zou et al. 2008, Garver et al. 2009).  Frolet et al. (2006) used this 
transient immune stimulation to show that Toll pathway activation decreases the 
Plasmodium berghei parasite burden, whereas depletion of the Rel1 transcription factor 
increases infection levels in mosquito midguts. These authors suggest that Toll pathway-
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regulated effector molecules are constantly in circulation and can immediately attack an 
invading pathogen. Transcriptional activation subsequent to pathogen challenge is then 
used to replenish molecules used during the initial insult (Frolet et al. 2006). However, 
Toll pathway-mediated killing of parasites may not be relevant to all parasite species. P. 
berghei infection of An. gambiae, An. stephensi and An. albimanus, as well as P. 
gallinaceum infection of Ae. aegypti appear to be controlled through Toll pathway 
activation, while P. falciparum infection of various anopheline mosquitoes is affected to 
a lesser degree by the Toll pathway (Zou et al. 2008, Garver et al. 2009). 
 Initiation of signaling through a second innate immune pathway, the immune 
deficiency (IMD) pathway, protects mosquitoes from infection with the human malaria 
parasite P. falciparum (Meister et al. 2005, Garver et al. 2009, Dong et al. 2012). 
Signaling events within this pathway culminate in the expression of various effector 
genes mediated by the Rel2 transcription factor. Basal levels of IMD pathway-mediated 
gene expression are constantly regulated by a shortened splice variant of Rel2, while the 
full-length isoform is continuously present in the cell cytoplasm, but inactive until 
immune stimulation occurs (Meister et al. 2005, Luna et al. 2006). Pathway activation 
stimulates the cleavage of the full-length isoform, exposing the nuclear localization signal 
and causing nuclear translocation of the transcription factor and a subsequent increase in 
the transcription of immune effectors. Garver et al. (2009) used transient depletion of the 
negative regulator caspar to show that induction of the IMD pathway renders mosquitoes 
nearly refractory to P. falciparum infection. Interestingly, both the Toll and IMD 
pathways are mosquito species-independent, in that multiple mosquito species use the 
same pathways to combat pathogens, but are Plasmodium species-dependent.  
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 The third major immune pathway, the Jak/Stat pathway, is named for the kinases 
(Jak) and transcription factors (STAT) that control its activation. The pathway has 
antiviral activity in Ae. aegypti (Souza-Neto et al. 2009) and can control late stage 
Plasmodium infection in Anopheles spp. (Gupta et al. 2009).  Two STAT transcription 
factors, STAT-A and STAT-B, have been identified in An. gambiae, while only one 
STAT is present in Ae. aegypti. In An. gambiae, STAT-B modulates the transcription of 
STAT-A, the ancestral transcription factor and predominant form in adult mosquitoes. 
Translocation of STAT-A to the nucleus leads to up-regulation of anti-pathogen effector 
molecule expression. Recently, the pathway has been shown to mediate the killing of P. 
falciparum and P. berghei parasites after midgut invasion (Gupta et al. 2009). In 
experiments similar to those described above for the Toll and IMD pathways, activation 
of the Jak/STAT pathway via depletion of the negative regulator SOCS decreases the 
density of P. berghei late oocysts, indicating that the pathway is important for anti-
Plasmodium responses in Anopheles mosquitoes (Gupta et al. 2009).   
 Activation of any innate immune pathway leads to an increase in the production 
of various anti-pathogen molecules. A large number of anti-Plasmodium effector 
molecules have been identified, including leucine-rich repeat domain-containing proteins, 
fibrinogen-related proteins, C-type lectins, and others (Cirimotich et al. 2009). Of 
particular interest is the thioester-containing protein TEP1, which has been shown to be 
crucial for mosquito defense against Plasmodium parasites (Levashina et al. 2001). TEP1, 
a homolog to the vertebrate complement system molecule C3, is constitutively secreted 
by hemocytes into the mosquito hemolymph, allowing it to interact with pathogens soon 
after they infect the mosquito (Levashina et al. 2001). Once a pathogen is detected, TEP1 
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binds to the surface of the invading microbe and promotes phagocytosis and, therefore, 
clearance of the intruder (Moita et al. 2005). TEP1 expression is induced in response to 
both Toll and IMD pathway activation, reflecting the molecule’s importance in mosquito 
innate immune responses (Levashina et al. 2001, Blandin et al. 2004, Garver et al. 2009). 
 The dissection of the mosquito immune response to human pathogens has led to 
the discovery of immune pathway factors and downstream anti-pathogen effectors that 
can potentially be used to render the mosquito resistant to these infections through 
transgenic tissue- and infection stage-specific over-expression. 
 
1.3 Mosquito transgenesis 
 The introduction of novel genetic elements into mosquito genomes has become a 
powerful system for the study of mosquito immunity and has the potential to be used for 
future control of mosquito populations and to reduce the vectorial capacity of mosquitoes 
for human pathogens. In transgenesis, a mobile DNA element is used to introduce a gene 
of interest into the mosquito germline. This gene of interest is placed under the control of 
a specific promoter, which determines the tissue specificity and temporal expression of 
the transgene and makes it possible to express the gene only when induced, and only in 
certain tissues. Tools and methodologies for the genetic modification of Anopheles and 
Aedes mosquitoes have been developed and widely used to study various aspects of the 
vectors’ biology. Successful transformation of mosquitoes was first achieved in Ae. 
aegypti (Coates et al. 1996, Jasinskiene et al. 1998) and soon followed by An. stephensi 
(Catteruccia et al. 2000), An. gambiae (Grossman et al. 2001) and An. albimanus (Perera 
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et al. 2002), leading to the creation of many different strains of transgenic mosquitoes in 
each of these species, and new strains of additional species continue to be made. 
 In Aedes mosquitoes, transgenesis has been successfully used to identify Rel1-
driven gene expression as a major component of anti-fungal immunity (Bian et al. 2005). 
It has also been used to show that Rel2-driven gene expression provides a defense against 
systemic bacterial challenge and P. gallinaceum infection (Shin et al. 2003, Antonova et 
al. 2009) and that RNA interference is crucial for antiviral defense (Khoo et al. 2010). 
2010). Similarly, Rel-2 overexpressing An. stephensi mosquitoes have been used to 
profile the global transcriptomic and proteomic changes brought about by Rel-2 
induction, and have identified Rel-2 both as controlling the mosquito defense against P. 
falciparum, as well as driving expression of numerous immune and non-immune genes. 
Transgenesis has also been used in both Aedes and Anopheles mosquitoes to express 
heterologous genes for the purpose of altering vector competence (Cirimotich et al. 
2011).  
 In order to affect the mosquito’s vectorial capacity for a given pathogen, 
transgene expression must be driven in a relevant tissue, for instance the midgut, and at 
the appropriate time, i.e., when the pathogen has invaded that particular tissue. Midgut-, 
fat body- and salivary gland-specific promoters have been utilized to decrease vector 
competence in transgenic mosquitoes (Franz et al. 2006, Mathur et al. 2010, Isaacs et al. 
2011). Mating of separate transgenic lines may eventually be used as a strategy to induce 
transgene expression in a single mosquito at multiple time points and locations, 
increasing the chances that pathogen development will be negatively affected and 
minimizing the possibility that the pathogens will be able to evade the immune response. 
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The implementation of transgenic technologies that utilize the mosquito innate immune 
system to combat vector-borne disease can largely be achieved in three ways: (1) over-
expression of a pathway activator, such as a transcription factor, to turn on the expression 
of anti-pathogen molecules; (2) depletion of negative regulators of a pathway through the 
expression of a hairpin transgene, again activating that specific pathway; and (3) over-
expression of immune genes/effector molecules that directly affect the pathogen. Each 
approach has advantages and disadvantages, but regardless of the mechanism, the end 
result is a less suitable host environment for pathogen development.  
 The first and third strategies have previously been used experimentally in Ae. 
aegypti to demonstrate that this principle may eventually be applied to the engineering of 
pathogen-resistant mosquito populations. As mentioned above, Rel2 has been over-
expressed in Ae. aegypti in order to impede the development of P. gallinaceum parasites 
(Antonova et al. 2009). When Rel2 is expressed under the control of the vitellogenin 
promoter, which is inducible in the fat body of the mosquito upon blood feeding, the 
transcription of a number of antimicrobial peptides (AMPs) is induced. These transgenic 
mosquitoes are more resistant than non-engineered mosquitoes to the establishment of P. 
gallinaceum infection in the midgut and sporozoite production in the hemolymph 
(Antonova et al. 2009). In follow-up studies, Kokoza et al. (2010) engineered Ae. aegypti 
mosquitoes to over-express the AMP genes cecropin A and defensin A directly, rather 
than inducing the entire Rel2-mediated pathway. Separate transgenic mosquito lines were 
engineered to induce either cecropin A or defensin A, or both together, under the control 
of the vitellogenin promoter. Regardless of the configuration, transgenic expression of 
these genes decreased parasite development and completely abolished the vectorial 
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capacity of the mosquitoes for parasite transmission, as measured by sporozoite 
production (Kokoza et al. 2010).  
 Similarly, the first and second strategies have been pursued in An. stephensi 
mosquitoes, and the first in An. gambiae. As in Ae. aegypti, mosquitoes of these two 
species have been made that overexpress both their own immune genes as well as novel, 
non-native, anti-Plasmodium effectors such as single-chain antibodies and various toxins 
linked to pathogen recognition motifs (Ito et al. 2002, Dong et al. 2011, Dong et al. 2012, 
Isaacs et al. 2012). These mosquitoes have been shown to have greatly increased 
resistance to infection with the human malaria parasite, P. falciparum, as well as alter the 
expression of large and varied gene families, both with and without known immune 
function (Pike et al. 2014). Also as in Aedes mosquitoes, these effects were seen under 
different promoters, indicating that the same gene expressed at different times or in 
different tissues can have a profound effect on Plasmodium infection levels (Dong et al. 
2011).  
 While manipulation of the mosquito immune system allows a variety of ways to 
target human pathogens in the vectors, there are also a variety of non-mosquito constructs 
that can lead to the same result (Isaacs et al. 2012). The use of toxins and antibodies from 
other organisms creates a variety of killing mechanisms not found within mosquitoes and 
which the pathogens will not have encountered before, and against which they will not, 
therefore, have natural resistance. In addition, multiple of these killing mechanisms could 
be combined into one mosquito, or combined with mosquitoes bearing enhanced immune 
systems, leading to mosquitoes that are more resistant to the pathogens and which reduce 
the possibility of the development of parasite resistance to the defense mechanisms. 
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However, these additional mechanisms are truly transgenic (based on non-mosquito 
genes) and may be met with increased public resistance when released.  
 In addition to using genetic modification to increase the expression of immune 
genes to fight pathogen infection, genetically modified mosquitoes have also been made 
that suppress the natural population to reduce the number of infectious bites.  Reduction 
of pest populations has formed a component of the management of numerous insect 
species, both in agriculture and public health, and has been aided by genetic tools. The 
sterile insect technique (SIT) has been used for decades to reduce pest populations 
successfully, including in projects such as screwworm eradication in many areas and 
reductions in mosquito populations for disease control (Wyss 2000, Oliva et al. 2013a).  
Traditionally, SIT has depended on radiation or chemical based sterilization of male 
mosquitoes that are then released to mate wild-type females. However, these methods 
have serious drawbacks such as reduced male fitness and mating competition, as well as 
needing the constant rearing of large numbers of mosquitoes for release. Creating 
genetically modified mosquitoes for release of insects with a dominant lethal gene 
(RIDL) has been proposed and initial experiments have been carried out as an alternative 
to these traditional methods (Phuc et al. 2007). 
 RIDL depends on the use of male mosquitoes carrying a dominant lethal gene. 
This gene will kill all offspring of a mating between the genetically modified male and 
any female mosquito (Alphey et al. 2013). Mosquitoes would be reared in large numbers, 
the females would be removed and the males released into the wild where they would 
mate with wild-type females.  Any offspring from these matings would not be viable, 
causing a decrease in the population of mosquitoes and decreasing local disease 
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transmission. Mosquitoes such as this have been created by Oxitec, and experimental 
releases have begun in multiple locations around the world (Phuc et al. 2007).  Oxitec has 
tested limited releases of their OX513A strain of RIDL mosquitoes in both the Cayman 
Islands and Malaysia, and company releases report an 80% decrease in Ae. aegypti 
populations following the release of 3 million genetically modified mosquitoes in the 
Cayman Islands (Harris et al. 2012).  Further studies are ongoing in Brazil to better 
determine the necessary release rates and conditions, and other sites are being considered 
for limited or widespread releases (Oxitec.com 2014). 
 While RIDL mosquitoes have been created and are being tested, there are 
drawbacks to this approach. First, for the method to be effective, a high proportion of the 
matings must result in sterility, and the genetically modified mosquitoes must be able to 
compete with the wild-type males.  In cage trials, the OX513A line shows similar mating 
success to wild-type males and nearly 100% sterility, but this may not hold true in the 
field (Bargielowski et al. 2011, Massonnet-Bruneel et al. 2013). In Oxitec mosquitoes, 
the population is maintained in the laboratory by controlling the lethal gene with a 
repressible promoter that is turned off in the presence of tetracycline (Phuc et al. 2007). 
When larvae from incompatible matings are maintained on a diet containing tetracycline, 
they live, overcoming the lethality. However, the same could occur in the wild if 
tetracycline is found in natural water sources. Tetracycline is a commonly used antibiotic 
on both farms and for human disease, and therefore may be present in runoff.  Both the 
amount of tetracycline in natural mosquito habitats and the amount necessary to repress 
expression of the lethal gene need to be determined in order to understand if this will be a 
problem for widespread releases.  
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 There are potential ecological consequences to removing mosquitoes from an 
area, which need to be investigated further.  However, these concerns also exist with 
current insecticide based mosquito control methods, and RIDL may be superior as there 
will be fewer off-target effects of releasing these mosquitoes than using broad-spectrum 
insecticides. It is also possible that mosquitoes in the field would evolve to survive the 
lethal gene, rendering the intervention ineffective.  Traditional sterilization methods 
based on radiation or chemical treatment damage the DNA in many random areas at 
once, making evolution to avoid the damage difficult, whereas RIDL targets a single 
DNA location each time, making evolution away from that sequence possible (Oliva et 
al. 2013a). This is a potential problem with all interventions, including traditional control 
means, and can be overcome by developing other dominant lethal genes in the 
mosquitoes for subsequent releases if needed, efforts toward with are already underway.  
 In order for population replacement or suppression to succeed, the mosquitoes 
must be able to successfully mate with the wild-type population at a high level or in its 
entirety. Any significant number of wild-type mosquitoes left in an area with high levels 
of transmission indicated by a high entomological inoculation rate will lead to continued 
transmission in the area. The ability of mosquitoes to replace or suppress the wild-type 
population successfully depends on the fitness costs of the genetically modified 
mosquitoes relative to their wild-type conspecifics, the size of the original population, 
and the existence of a gene driver, as well as logistical issues related to rearing and 
releasing large numbers of mosquitoes (Boete and Koella 2002). 
 
1.4 Fitness of genetically modified mosquitoes 
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 It has generally been assumed that the genetic modification of any organism will 
lead to a decrease in the fitness of that organism. This is especially true when discussing 
modifications meant to increase the immune activity of the organism (Marrelli et al. 
2006). Part of this assumption is based on early studies of immunity that showed a fitness 
cost, and part depends on the assumption that if increased immunity were not detrimental 
it would have evolved on its own, both of which are flawed arguments (DeVeale et al. 
2004). Early studies on the effects of insect immunity on fitness were largely performed 
in Drosophila, and often depended on infecting the fly with a pathogen and observing the 
fitness effects (McKean and Nunney 2001, McKean et al. 2008, Imroze and Prasad 
2012).  For instance, injecting a large number of bacteria directly into the hemocoel of 
Drosophila was shown to lead to a significantly shorter lifespan and fewer offspring, 
especially in food-limited situations (Bedhomme et al. 2004, Zerofsky et al. 2005). 
Similarly, flies that are able to fight off invasion by the parasitoid was Acyrthosiphon 
pisum show reduced size and fecundity, again potentially due to immune activation 
(Kraaijeveld et al. 2002). However, studies of this type ignore the effects of the bacterial 
infection and injury on the fly. An injection such as that will create a systemic sepsis that 
is likely to have effects on the fly that go far beyond those caused by the immune system 
itself.  
 Likewise, the assumption that increased immunity would have evolved on its own 
if there were no fitness cost to doing so assumes that there is a fitness cost to infection 
with the pathogen. If pathogens have no fitness cost prior to the first batch of offspring 
there will be no selective pressure leading to a stronger immune system, regardless of any 
fitness cost of immunity or lack thereof. Pathogens that infect mosquitoes, especially 
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human pathogens, often have an incubation period of three or more days before reaching 
high numbers, during which time the female is able to lay her first batch of eggs.  
Therefore, even if the pathogen does cause a fitness cost it will not take effect until after 
reproduction has happened, and will not put pressure on the mosquito to evolve increased 
immunity. 
 While there has been significant research into the evolutionary costs of increased 
immune deployment in Drosophila, similar studies in mosquitoes are limited and the 
results of Drosophila studies are only as relevant as the model organism employed: while 
Drosophila serves as a valuable genetic model, there are many differences between flies 
and important disease vectors.   The fact that mosquitoes and other vectors of human 
disease are hematophagous adds a new dimension of complexity to their fitness, given 
that a blood meal may provide sufficient nutrients to make up for any reallocation of 
resources for the purpose of creating immune effectors.  Conversely, the acquisition and 
digestion of a blood meal both require significant energy expenditure, given the challenge 
of finding a suitable host, breaking down the blood proteins to useable units and dealing 
with the many toxic compounds produced during blood digestion, such as heme and 
reactive oxygen species (Zhou et al. 2007). This necessary energy usage may only 
compound any energy shortages caused by immune deployment, again leading to a 
complex and somewhat unpredictable set of interactions that will affect the fitness of 
mosquitoes that are found or created to be refractory to disease transmission. 
 Multiple groups have begun to study the fitness of genetically modified 
mosquitoes under a variety of conditions (Catteruccia et al. 2003, Irvin et al. 2004). Initial 
experiments in this regard appeared to corroborate the assumption that there would be a 
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fitness effect of genetic modification. However, these experiments were done in lines 
with constitutive activation of the inserted gene, which may have been very energetically 
costly (Catteruccia et al. 2003, Irvin et al. 2004). More recent creation of genetically 
modified mosquitoes, whether based on upregulation of their own immune systems or 
with genes from other organisms inserted, has focused on transient immune activation to 
ameliorate these effects (Moreira et al. 2004). To achieve this, blood-meal inducible 
promoters such as the vitellogenin and carboxypeptidase promoters have been used. 
Genes under the control of both of these promoters are upregulated soon after a blood 
meal is consumed and return to baseline levels within two days (Dong et al. 2011). 
 There is, however, evidence of a potential effect of immune activation on 
mosquito fitness, as has been observed in Drosophila.  A number of studies have 
indicated that infection of Anopheles mosquitoes with Plasmodium parasites reduces the 
lifespan and reproductive output of the mosquitoes (Hogg and Hurd 1995, Anderson et al. 
2000).  Ae. aegypti adults selected to be resistant to P. gallinaceum are significantly 
smaller, lay fewer eggs, and have shorter lifespans than susceptible conspecifics (Yan et 
al. 1997).  These differences are not unexpected, given that similar results have been 
observed in Drosophila and because there is significant conservation between the 
Drosophila and mosquito immune systems (Christophides et al. 2002).  Conversely, male 
An. gambiae from a line selected for increased melanotic encapsulation of P. yoelii show 
an increase in fecundity, as measured by the number of offspring born to their mates 
(Voordouw et al. 2008).  These studies, taken together, indicate that an increased immune 
activity in mosquitoes may have disparate fitness effects, depending on the host-pathogen 
system, and that not all effects are negative.  Also, careful measurement of the fitness 
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costs imposed on the mosquito by both infection with P. yoelii and resistance indicated 
that increased melanotic encapsulation of parasites has the same cost; both in terms of 
lifespan reduction and egg hatch rate (Hurd et al. 2005).  Thus, a moderate fitness cost 
resulting from increased immune activation may be acceptable, since it will simply offset 
the fitness cost of infection.   
 More recent studies with genetically modified mosquitoes transiently 
overexpressing immune genes have shown little or no reduction in lifespan, fecundity or 
size in multiple laboratory experiments, and have even been able to persist during mixed-
cage trials (Dong et al. 2011, Smith et al. 2013b).  In mixed-cage trials with wild-type 
mosquitoes, these genetically modified mosquitoes have actually been able to increase in 
prevalence when maintained on P. berghei infected blood at each generation (Smith et al. 
2013b). While large-scale cage and field trials must be done to ensure this effect stays 
true for larger populations, these recent results show no reason to believe there is a 
significant fitness cost associated with transient immune deployment. This may be due to 
the fact that mosquitoes have an abundance of available protein immediately after a blood 
meal, allowing them to expend extra energy on overexpressing the immune genes during 
the time they are active. By the time the blood-meal based energy is depleted the 
expression of the gene has returned to normal and no extra energy is needed for egg-
laying and general living. Similarly, during the time of gene overexpression the 
mosquitoes will largely be resting to digest the blood meal and may not need that much 
energy. 
 In addition to any fitness effects caused by immune activation in mosquitoes, 
there may be effects related to genetic manipulation (Marrelli et al. 2006).  Transgenesis 
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allows the introduction of novel genes that can lead to refractoriness and also allows 
transient immune activation instead of constitutive up-regulation, which can limit any 
negative effects of immune over-expression, as discussed above.  However, the creation 
of transgenic mosquitoes can carry with it an inherent cost to the transformed insect. 
Genetically modified mosquitoes made to express green fluorescent protein constitutively 
after insertion with the piggybac transposable element have a competitive disadvantage 
when compared to both wild-type and inbred, but not transgenic, mosquitoes when reared 
together (Koenraadt et al. 2010). However, the negative effects of transgenesis are only 
compounded when limited food resources are provided and the adult transgenic 
mosquitoes have fewer energy reserves available.  Thus, exogenous gene expression 
utilizes energy that would otherwise be used for development (Koenraadt et al. 2010).  In 
a separate study, Li et al. (2008) observed no measurable effect on the adult survivorship, 
egg hatch rate or larval-to-pupal viability in An. stephensi mosquitoes that express the 
exogenous protein SM1 under the carboxypeptidase promoter.  However, during the 
same study, when the authors kept cages containing both transgenic and wild-type 
mosquitoes for multiple generations, they noticed that the frequency of genetically 
modified mosquitoes decreased over time.  They attributed this effect to a lower 
reproductive capability of the transgenic mosquitoes or a negative consequence of the 
insertional mutagenesis, and not the expression of the transgene (Li et al. 2008). 
Conversely, the same group also observed that the transgenic mosquito line expressing 
SM1 has a fitness advantage over wild-type conspecifics after infection with P. berghei 
(Marrelli et al. 2007).  This effect was seen not only in the form of a higher fecundity and 
longer lifespan after infection in one generation, but also in the gradual replacement of 
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wild-type mosquitoes by the genetically modified mosquitoes over multiple generations 
when fed on P. berghei-infected mice, but not when fed on uninfected mice (Marrelli et 
al. 2007).  Similar effects were found with mosquitoes bearing a phospholipase A(2) gene 
and maintained on P. falciparum infected blood, though these studies showed that the 
effects depended on the genomic insertion location of the gene (Smith et al. 2013b). 
These studies indicate that any effects of transgenesis on the mosquitoes will depend on 
the environment in which the mosquitoes live and the genomic integration area of the 
transgene.  These types of effects can be avoided by selection of the most fit transgenic 
lines after many have been created; however, if the effects are only slight reductions in 
lifespan or fecundity, they may not be noticed during the selection process.   
 New methods of transgenesis that allow site-specific integration of the transgenes 
have recently been developed, allowing the selection of the insertion location and 
minimization of gene disruption (Labbe et al. 2010, Meredith et al. 2013).  However, it is 
more likely is that any transgene introduced into the mosquito will lead to effects that 
reflect a reallocation of resources to producing the transgene, as previously described for 
immune activation.  Also, an inserted gene may have more widely ranging effects than 
initially predicted, potentially leading to greater resource use or significant changes in 
gene expression.  For instance, if an inducible transgene that affects both immune and 
developmental functions is introduced, the result may be a differential expression of 
numerous genes beyond the initially targeted immune genes as has been shown in An. 
stephensi, and therefore widespread effects on the mosquito and a greater fitness cost.  
Such effects, however, can be minimized by carefully selecting the gene to be introduced, 
expressing it in a highly tissue and stage-specific manner and creating multiple transgenic 
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lines, then monitoring and selecting the line with the least observable effect on lifespan, 
fecundity and other fitness measures before the insects are released.  If multiple 
transgenic lines are created with the same insert through random integration, both the 
expression of the transgene and the effects of integration on other genes can vary greatly.  
This variability is the result of position effects, i.e. variability in the expression of a gene 
that is a consequence of its location on the chromosome, and therefore its relative 
proximity to other genes or regulatory elements that act on all genes within their reach 
(Wilson et al. 1990).  Furthermore, the effects of the transgene on neighboring genes will 
vary greatly depending on its final location: whether it has interrupted a gene or a 
regulatory sequence, or the interactions between the two.  Thanks to our knowledge of 
these effects, careful design of transgene constructs and selection of transgenic strains 
can minimize these effects of transgenesis. 
 It is also important to note that a small decrease in the fitness of a vector as a 
result of increased immune deployment or transgenesis would not preclude using this 
system as a vector-borne disease control technique. As discussed above, the vectorial 
capacity of an insect vector depends on numerous factors, including both the vector 
competence and daily survivorship of the vector.  Activation of a specific arm of the 
innate immune system so as to reduce the ability of the mosquito to transmit a pathogen 
is, in effect, decreasing the vector competence of the mosquito and producing a related 
decrease in vectorial capacity.  However, a decrease in daily survivorship, such as one 
caused by a fitness cost associated with gene expression, will also decrease vectorial 
capacity.  Likewise, a decrease in survivorship or a decrease in the number of eggs 
produced by each generation may lower the mosquito density relative to human hosts, yet 
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another factor that can lead to an overall decrease in vectorial capacity.  Overall, a slight 
decrease in mosquito fitness leading to decreased fecundity and lifespan can lead to a 
large decrease in vectorial capacity, especially if combined with an additional decrease in 
vector competence.  However, any decreases in fitness must be limited in scope so that 
they do not prohibit the vector from invading the natural population and maintaining a 
normal population; otherwise, the modified mosquitoes will never reach high enough 
numbers to be a viable tool for vector control.   
 Use of strong gene drivers, such as homing endonucleases or medea elements, 
should be able to mitigate some of the fitness cost and still drive the genes of interest into 
the natural population (Cirimotich et al. 2011).  This goal can be met by increasing the 
probability that a gene will be spread to the mosquitoes’ offspring or by giving 
mosquitoes bearing the gene driver a significant fitness advantage over those that lack the 
gene driver, such as by killing offspring that lack the driver.  As long as the transgene 
being introduced into the mosquito population is linked to the gene driver, it will be 
carried with the driver, and the genetically modified mosquitoes will replace the wild-
type population to a transgenic population.  However, if the fitness cost is too high, even 
a strong gene driver will not be able to overcome the negative effects of transgenesis, and 
the population will not be replaced.   
 Numerous studies have also been performed on the fitness of RIDL strains of 
mosquitoes. These studies focus on the mating ability of the males, as this strategy is 
based on the release of large numbers of males that will mate with the wild-type females, 
causing incompatibility (Bargielowski et al. 2011, Massonnet-Bruneel et al. 2013). 
Similar strategies have been successfully employed to reduce crop pests using SIT or 
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mosquitoes using Wolbachia infected mosquitoes, and the fitness of RIDL strains must 
be evaluated in comparison to these previous efforts (Laven 1967, Wyss 2000). SIT is 
accomplished by either chemically sterilizing or irradiating the males, which leads to a 
decrease in fitness due to the large amounts of damage done during sterilization (Oliva et 
al. 2013b, Yamada et al. 2014). Reduced application of the chemosterilant or radiation 
can lead to less fitness cost, but this can also lead to an increased number of non-
sterilized mosquitoes being released, which reduces the efficacy of the program. RIDL 
males have been engineered and selected to have minimal fitness effects, though some 
small fitness effects have been observed (Bargielowski et al. 2011, Massonnet-Bruneel et 
al. 2013). This, however, is less than the effect caused by irradiation, though more studies 
are necessary to determine the full effects of this minimal fitness cost in the field. 
 
1.5 Logistics of genetically modified mosquito deployment 
 In order to use genetically modified mosquitoes as part of a malaria control 
program the proper release ratios must be established, the mosquitoes must be reared in 
appropriate numbers and those mosquitoes must be released in the correct areas. Many 
models have been created to determine the proper release ratios of genetically modified 
mosquitoes for both population replacement and RIDL(Boete and Koella 2002, 2003, 
Koella and Boete 2003). In order for population replacement to be effective in an area 
with sustained malaria transmission the population must be completely replaced, as even 
a few remaining wild-type mosquitoes(Alphey et al. 2011) may be able to keep the 
transmission cycle going (Boete and Koella 2002). In order to make this happen, the 
fitness costs must be minimal, a goal which is in sight.  Additionally, either a gene driver 
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must be used or the population must be suppressed to the point at which the genetically 
modified mosquitoes overwhelm the wild-type population (Marshall 2009, Robert et al. 
2013). The drive mechanism must have the power to drive the transgene to near-fixation 
in the native population and be sufficiently well linked to the transgene to avoid 
separation from it. Gene drivers, such as transposable elements, medea-like elements and 
homing endonucleases have been suggested for use in this regard, but have yet to be 
created for wild-type mosquitoes (Sinkins and Gould 2006, Chen et al. 2007, 
Windbichler et al. 2011).  The bacterium Wolbachia has also been suggested as a gene 
driver and has recently been introduced into An. stephensi mosquitoes, but this 
introduction causes a large decrease in fecundity in the mosquitoes, which may hamper 
its usefulness (Walker and Moreira 2011, Bian et al. 2013, Joshi et al. 2014). Further, no 
one has investigated the use of Wolbachia in this way, and it is possible that the gene 
would become unlinked from the infection, rendering the driver ineffective. 
Alternatively, models suggest that population suppression followed by inundative 
releases may eliminate the need for such a gene driver, but no large-scale field trials have 
yet shown this to be an effective method (Robert et al. 2013).  The necessary release 
ratios for RIDL mosquito releases have also been modeled, and experiments are ongoing 
now with the OX513A Oxitec line to determine if these estimates are correct and further 
refine them under field conditions (Alphey et al. 2011). 
 Once the release ratios for genetically modified mosquitoes are established, the 
mosquitoes must be reared and released. While many insectaries operate worldwide, most 
cannot rear mosquitoes at the scale necessary to maintain this sort of intervention. 
However, advancements in both rearing techniques and technologies for sorting 
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transgenic from wild-type larvae have advanced to the stage at which large-scale rearing 
is possible (Balestrino et al. 2012, Marois et al. 2012). The OX513A Oxitec line is being 
reared in very large numbers close to sites for release, indicating that similar efforts 
would be successful in other areas (Harris et al. 2012). After rearing, mosquitoes must be 
released over a large area in order for them to mate with as many wild-type conspecifics 
as possible, regardless of which strategy is being employed (Kiszewski and Spielman 
1998). This sort of release has been accomplished in other insect species for control and 
could easily be adapted to mosquito releases (Wyss 2000). Engaging the public is one 
possible way to increase the distribution area, and may serve to help target mosquitoes to 
the areas occupied by humans, reducing incidence in those areas more quickly. 
  
1.6 Public perception of genetically modified mosquitoes 
 Even if all other obstacles were overcome and a genetically modified mosquito 
strain was ready for worldwide deployment today, public perception of the releases 
would be necessary to assess.  Many people, both in the developing and developed world, 
are highly resistant to genetically modified organisms in general, and may, therefore, be 
opposed to the idea of releasing genetically modified mosquitoes. This often stems from a 
misunderstanding of the genetic modifications and can hamper the employment of highly 
useful strains, both in agriculture and in other settings. By engaging the public and 
educating them both about the methods used to create the genetically modified 
mosquitoes and how these strains can help them they may be more willing to accept them 
(Subramaniam et al. 2012). Similar efforts have been necessary for past mosquito 
releases with non-genetically modified mosquitoes, and have met with success (Laven 
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1967). Studies of public perception also indicate that people may not resist this type of 
release if it is meant to benefit them (Amin and Hashim 2013, De Freece et al. 2014). The 
scourge of malaria is great enough that a long-term intervention such as replacing or 
removing the mosquito population will be popular, especially once successfully 
implemented in one area. OX513A Oxitec releases have occurred in three separate 
countries and have not met with excessive public resistance, and there is hope that 
expanded use of this strain or further releases with other strains would meet with similar 
acceptance (Subramaniam et al. 2012). 
 
1.7 Conclusions 
 Due to the failures of previous vector-control efforts to remove mosquito-borne 
diseases from many areas, new tools such as genetically modified mosquitoes are 
increasingly necessary. Strains to be used for both population replacement and population 
suppression have been developed in laboratories, and evaluation of their usefulness for 
vector-control in the field is ongoing. While the two strategies differ in many ways, the 
components necessary for their success are similar. The mosquitoes must be fit enough to 
compete with their wild-type conspecifics, reared in large numbers and released over a 
large area to be successful, solutions to all of which are currently being investigated. 
These experimental results, along with the ongoing releases of Ox513A Oxitec strain 
mosquitoes in Brazil indicate that genetically modified mosquitoes may soon become a 
part of global vector-control efforts. Continued research will only yield improvements in 
this regard, but large-scale field trials should be pursued to advance the field. The 
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potential usefulness of such mosquitoes cannot be understated, and implementation of 
these control strategies should be pursued as soon as safely possible.
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Chapter 2: Characterization of the Rel2-regulated transcriptome and proteome of 
Anopheles stephensi identifies new anti-Plasmodium factors. 
 
(Published September 2014 in Insect Biochemistry and Molecular Biology 52:82-93) 
2.1 Introduction 
 Mosquitoes are vectors for many important human pathogens, including viruses, 
filarial worms, and apicomplexan parasites.  A number of Plasmodium spp. parasites, 
vectored exclusively by Anopheles spp. mosquitoes, cause human malaria.  Because of 
difficulties in the distribution of anti-malarial chemotherapeutics and the rise of drug 
resistance in the parasite, vector control remains at the forefront of malaria control 
efforts.  However, after decades of insecticide spraying, bed net distribution, and habitat 
remodeling, the disease remains established, so novel vector-control methods must be 
developed.  Recently, methods have been developed to generate genetically modified 
mosquitoes (Ito et al. 2002), and various strategies based on their release are being 
investigated for malaria control.  Conversion of a natural mosquito population to a 
transgenic population that overexpresses anti-Plasmodium immune system activators or 
effector molecules could represent one such method, and multiple mosquito lines 
expressing such transgenes in different tissues have already been developed (Dong et al. 
2011, Dong et al. 2012). 
 Mosquitoes possess an innate immune system that is capable of responding to, 
and controlling, infection by diverse pathogens, including bacteria, viruses, and 
apicomplexan parasites (Cirimotich et al. 2009, Garver et al. 2009).  Two immune 
pathways, the Toll and immune deficiency (IMD) pathways, have been extensively 
studied in both Drosophila and mosquitoes.  Both pathways recognize invading 
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pathogens through the association of host pattern recognition receptors (PRR) with 
pathogen associated molecular patterns (PAMPs), leading to a signaling cascade, nuclear 
localization of transcription factors, and subsequent induction of the expression of 
numerous immune effector molecules and anti-microbial peptides.  Invading pathogens 
are then killed by various mechanisms, such as phagocytosis and complement-like 
killing. 
 The nuclear translocation of the NF-κB transcription factor Rel2 leads to an 
induction of immune gene expression that constitutes the IMD pathway-mediated 
immune response (Meister et al. 2005).  The IMD pathway has been shown to regulate 
the mosquito’s resistance to P. falciparum infection (Garver et al. 2009), and numerous 
mosquito lines with inducible overexpression of the constitutively active short form of 
Rel2 have been created (Dong et al. 2011).  One such line (henceforth referred to as the 
CP15 line) uses the carboxypeptidase gene promoter to limit Rel2 overexpression to the 
midgut following a blood meal, while another line (the VG1 line) overexpresses the same 
Rel2 transgene under the control of the vitellogenin gene promoter, leading to fat body-
specific expression after a blood meal (Dong et al. 2011).  Both these lines exhibit a 
greatly reduced susceptibility to Plasmodium infection following an infected blood meal 
and may represent viable tools for future release as part of a malaria control program.  
However, immune pathways and their downstream transcription factors can regulate a 
large variety of both immunity and non-immunity related processes (Dong et al. 2006a, 
Xi et al. 2008a). Hence, the overexpression of the Rel2 transcription factor affects the 
immune system, but it is also likely to regulate other physiological processes entailing 
genes of diverse functions.   
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A majority of studies on the insect immune system have relied on infection with a 
pathogen and observation of the insect’s response to the insult (Zerofsky et al. 2005, 
McKean et al. 2008, Imroze and Prasad 2012).  Using transgenic mosquitoes that 
overexpress Rel2 in an inducible fashion provides a pathogen-independent system to 
study IMD pathway-regulated immune response and eliminates any confounding factors 
brought about by the presence of the infecting organism.  Zou and colleagues (Zou et al. 
2011) used a Rel2-overexpressing Aedes aegypti to study the IMD pathway-regulated 
transcriptome. 
 We used whole-genome oligonucleotide microarrays to study recombinant Rel2-
induced changes in mRNA abundance, as well as isobaric tags for relative and absolute 
quantitation (iTRAQ) to study changes in protein abundance after Rel2 overexpression in 
transgenic mosquitoes.  Measuring the expression levels of both mRNA and protein 
allowed us to look for correlations between transcript and protein abundance following 
up-regulation of a transcription factor.  We then used RNA interference (RNAi) assays to 
investigate a subset of genes, both with and without known immune function, for anti-
Plasmodium and anti-bacterial activity, leading to the identification of multiple novel 
anti-Plasmodium effectors.   
 
2.2 Materials and Methods 
Mosquito rearing 
A. stephensi Liston strain wild-type, CP, and VG transgenic Rel2-overexpressing lines 
(Dong et al. 2011) were maintained according to standard insectary procedures.  In brief, 
larvae were reared at low densities in trays and fed a combination of ground fish flakes 
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(Tetra) and cat food pellets (Purina).  Upon emergence, adults were maintained on a 12 
h/12 h light/dark cycle at 27° C with 80% humidity and constant access to a 10% solution 
of sucrose in water.  In order to stimulate egg production, adults were fed on ketamine-
anesthetized mice according to IACUC-approved protocols. 
 
RNA extraction and microarrays 
One-week-old adult female mosquitoes were given a human blood meal from water-
jacketed membrane feeders maintained at 37° C.  Mosquito tissues were dissected in 
sterile PBS as follows: midguts were collected at 6 and 12 h after blood feeding, while fat 
bodies were collected at 12 and 18 h after the blood meal.  Total mosquito RNA from 
dissected tissues was extracted using RNeasy kits (Qiagen) according to the 
manufacturer’s protocols and quantified on a NanoDrop spectrophotometer before quality 
assessment on an Agilent Bioanalyzer 2100.  Probes were synthesized using 200 ng of 
RNA and the Low-Input RNA Labeling Kit (Agilent) according to the manufacturer’s 
protocol.  These probes were hybridized to a custom-designed Agilent microarray slide, 
which was scanned with an Axon GenePix 4200AL scanner at 2-µm resolution.  After 
scanning, statistical analysis was performed using the TIGR, MIDAS, and TMEV 
software packages (Dudoit et al. 2003), following standard laboratory protocol (Dong et 
al. 2006a), and analysis was performed using a t-test, with a significance level of α=0.05.  
Changes in gene expression were considered significant if the absolute value of the gene 
regulation was >=0.75 on a log2 scale.  For each treatment, three biological replicates and 
one psuedoreplicate were performed.  The array was designed using Array Designer 
software (Premier Biosoft, www.premierbiosoft.com) and based on an early version of 
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the A. stephensi transcriptome obtained from Dr. Jake Tu of Virginia Polytechnic 
Institute and State University, and putative function and gene ontology (GO) terms were 
assigned to transcript sequences based on homology to previously annotated A. gambiae 
genes discovered by a blastn search (Altschul et al. 1990).  The blast search was 
performed against gene set AgamP3.7, downloaded from vectorbase.org; for each gene, 
the most significant hit was used for annotation, with a maximum e-value of 0.0001 used 
as a cutoff.  Any genes that did not have significant homology to any previously 
annotated An. gambiae genes were used for a blastn (Altschul et al. 1990) search against 
the non-redundant nucleotide database from NCBI to assign putative function if similar 
genes or conserved sequences were identified in other species.  While the gene with the 
highest blast homology between An. stephensi and  An. gambiae may not represent a true 
orthologue, the early state of the annotation of the An. stephensi genome leaves this as 
our best prediction. Seven genes were analyzed by qRT-PCR to verify the results of the 
microarray (Figure 2.1). 
 
Protein extraction and iTRAQ 
One-week-old adult female mosquitoes from the WT, CP, and VG lines were given a 
human blood meal from membrane feeders at 37° C.  Prior to the blood meal and 24 h 
afterward, mosquitoes were dissected in sterile PBS and their midguts and fat bodies 
collected.  Three replicates of 10 midguts or fat bodies were resuspended in lysis buffer 
(10 mM HEPES, 0.1 mM MgCl2, 0.1% Triton, and protease inhibitors [Roche]) and left 




Figure 2.1: qRT-PCR verification of microarray data.  7 genes upregulated in the 12 
hours PBM midguts samples of the microarray were chosen and their fold-change 
measured by qRT-PCR to verify their regulation.  Of the 7, 4 were similarly regulated as 
measured by qRT-PCR and all 7 were upregulated in at least one experimental condition. 
 
14,000 rpm for 30 min at 4°C.  The supernatant fraction was collected and used as the 
total protein extract.  Total protein concentration was measured by Bradford assay.  
Consistency among the three replicates was assessed by running 0.1 µg of total extract on 
a 4-12% Tris gel and silver staining.  Replicates were then combined and used for iTRAQ 
analysis:  50 µg of protein was reduced using 2 µL of 50 mM TCEP for 1 h at 60° C, 
cooled to room temperature, and incubated with 1 µL of 100 mM MMTS for 15 min in 
the dark.  Samples were then TCA-precipitated, and air-dried pellets were submitted to 
the Johns Hopkins School of Medicine Mass Spectrometry and Proteomics Facility for 
identification and relative quantitation using iTRAQ.  The samples were trypsin-digested, 
labeled with 8plex iTRAQ reagents, fractionated by both strong cation exchange and 
reverse phase chromatography, and identified by mass spectrometry using a LTQ 
Orbitrap Velos mass spectrometer (Thermo Scientific) as described in detail (Ross et al. 
2004, Guo et al. 2007, Martin et al. 2008, Pierce et al. 2008).  MS/MS spectra were 







Primer sequences (Forward/reverse) 
SCRBQ1 dsRNA TAATACGACTCACTATAGGGCTGTTCGAAGCGATACTCC 
TAATACGACTCACTATAGGTGTAGTGCCAGATGCGTTTC 
SCRBQ1 qPCR CGGACAGGTGCGTGGATCGG 
GCAGGAAGAGGTTGAGCGGGG 
AGBP1 dsRNA TAATACGACTCACTATAGGCTGGTGCGTGATCTGAAGAA 
TAATACGACTCACTATAGGGGGAATGTTGGTGTACGGTC 
AGBP1 qPCR GCCCGAGTGCACCCCGAAAC 
CGCGATCCGCCCGATTCCAG 
NPC2 dsRNA TAATACGACTCACTATAGGTCCAATCTGGTCATTGCAGA 
TAATACGACTCACTATAGGCTTCAACTCCACCGTAAGGC 
NPC2 qPCR GGCATGTGCCCCGTATCCCG 
CCTGCAGCTGGAAGCAGGTAACG 
A2MRAP dsRNA TAATACGACTCACTATAGGGTTCACGAAGGAAGAGCTGG 
TAATACGACTCACTATAGGACGAAATCCTGACTGTTCGG 
A2MRAP qPCR CGCGTTCCGTGGGTTGGACA 
CCGGCGAACGTTTTGCTCGC 
LRTP dsRNA TAATACGACTCACTATAGGGCTCGATCTTGACGAGAACC 
TAATACGACTCACTATAGGGTACAGCTCATCCAACCCGT 
LRTP qPCR CCGGCGAACGTTTTGCTCGC 
TCCGATCGAGCCGATCAAAG 
SRPN10 dsRNA TAATACGACTCACTATAGGTGGTCATTTCCCCGTTCTCG 
TAATACGACTCACTATAGGTCACTCTCGGCGAAGTTGAC 
SRPN10 qPCR TCGGACAGTCGAACAGCTTC 
CGAGAACGGGGAAATGACCA 
R2RSP1 dsRNA TAATACGACTCACTATAGGGCCGGAAAATGCAACGCTTA 
TAATACGACTCACTATAGGTGATAGTATGACACGCGGGC 
R2RSP1 qPCR AACGACATCGCACTGGTGAA 
TCGGAGTATGCGATGGGTTG 
R2RSP2 dsRNA TAATACGACTCACTATAGGGTCGGTAGCAGTTCCGTTGA 
TAATACGACTCACTATAGGCACTCGTGAGCACTTCCTGT 
R2RSP2 qPCR GCGGATGAGGACGATCAGTT 
TCGGAGTATGCGATGGGTTG 
SEPR1 dsRNA TAATACGACTCACTATAGGTACCGTACCAGATTGCGCTC 
TAATACGACTCACTATAGGCGGTTGGATGTACTGGCTGT 
SEPR1 qPCR ACAGCCAGTACATCCAACCG 
GCGTCCGTATCCCGAAATCA 




TRYPP qPCR CTAGGGTGCCTCGGCTAGTT 
TTCTTCGCCACTTCTCCACC 
ACEP dsRNA TAATACGACTCACTATAGGGAGAGCGGGAGATTAGTGGC 
TAATACGACTCACTATAGGCGTCGGCAAAGTAGCGATTG 
ACEP qPCR CTACAGCAACAGCTGACCGA 
CGTCGGCAAAGTAGCGATTG 
SEPR2 dsRNA TAATACGACTCACTATAGGTGAATGTCTCCGCCAGCTTT 
TAATACGACTCACTATAGGGAACCGTCTTGACGCGATTG 
SEPR2 qPCR CTACACCGTTGGGAGCAAGT 
AACCCACTCGCTGAAGTAGC 
 
Table 2.1: PCR primers used in this study. "Gene name" displays the name of the gene 
targeted by the primer, "Primer type" indicates whether this primer was used for the 
creation of dsRNA or for quantitative real-time PCR and "Primer sequences" gives the 
sequences of both the forward (top) and reverse (bottom) primers. 
 
Dr. Jake Tu (Virginia Polytechnic Institute and State University) using Mascot (Matrix 
Science) and Proteome Discoverer (v1.2 Thermo Scientific) with the high peptide 
confidence filter.  The resulting data were considered significant if the ratio of GM:WT 
protein levels was >0.75 on a log2 scale.  Sequences obtained from the mass spectrometer 
were compared to previously annotated A. gambiae gene sequences using blastp 
(Altschul et al. 1990) in order to assign them putative functions and GO terms.   
 
dsRNA-mediated gene silencing 
Double-stranded RNAs (dsRNAs) targeting selected genes were synthesized from PCR 
products using the HiScribe T7 in vitro transcription kit (NEB).  Adult female mosquitoes 
(3-4 days old) were anesthetized on ice and injected with 69 nl of 3 µg/µl dsRNA 
targeting a gene of interest or GFP as a control, then maintained under normal mosquito 
rearing conditions.  At 3 days post-injection, groups of 10 mosquitoes were collected for 
silencing efficiency measurement using qRT-PCR.  Primers used for the PCR 
amplification of oligos were designed using the Primer3 program 
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(http://frodo.wi.mit.edu) and are listed in table 2.1.  Silencing of the genes was verified 
by qRT-PCR 3 days post-injection (Figure 2.2). 
 
Quantitative Real-Time PCR (qRT-PCR) 
Total RNA used to verify gene knockdown was extracted from whole mosquitoes with 
their heads and legs removed, while total RNA used to verify the microarray results was 
collected from dissected midguts or fat bodies using a Qiagen RNEasy kit according to 
the manufacturer's instructions.  qRT-PCR was carried out using Sybr Green PCR Master 
Mix (ABI) on an ABI StepOnePlus Real-Time PCR System with the ABI StepOne 
Software.  Transcript abundance was normalized to mosquito ribosomal protein S7 gene 
levels and the -fold change of each gene was calculated using the ΔΔct method.  Primers 
were designed using the Primer3 program (http://frodo.wi.mit.edu) and are listed in table 
2.1. 
 
P. falciparum infections 
P. falciparum challenges were performed according to a standard laboratory protocol: 
Three days after dsRNA injection, mosquitoes were fed on human blood containing 
NF54W strain P. falciparum gametocytes through a membrane feeder at 37° C.  Unfed 
mosquitoes were discarded and mosquitoes were maintained as usual for 7 days, at which 
point their midguts were dissected and stained with 0.1% mercurochrome for oocyst 





Figure 2.2: qRT-PCR verification of dsRNA mediated gene knockdown.  mRNA was 
collected from dsRNA injected mosquitoes and used for qRT-PCR to measure the percent 
knockdown of the gene.  All genes showed greater than 50% knockdown. 
 
 
Enumeration of midgut bacteria 
The number of colony forming units (CFUs) of midgut bacteria for gene-silenced sugar 
or blood-fed mosquitoes was counted as previously described:  Mosquitoes were surface-
sterilized with ethanol and rinsed in PBS before their midguts were dissected into PBS.  
Midguts were then homogenized in PBS, and serial dilutions were plated onto LB agar 
plates and incubated at room temperature.  Three days after plating, the number of 
colonies per plate was counted, and the total number of culturable bacteria per midgut 
was calculated. Samples were collected for sugar-fed mosquitoes 3 days after gene 
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silencing, while other mosquitoes were provided a blood meal 3 days after gene 
silencing, with dissections being performed 24 h later. 
 
Statistical Analyses 
Statistical analyses were performed using the GraphPad Prism 5 software (Graphpad 
Software).  The tests used are indicated in the Results section and figure captions. 
 
2.3 Results and Discussion 
2.3.1 Expression of active Rel2 leads to broad transcriptome and proteome changes  
Using whole-genome microarrays, we compared the mRNA abundance of all predicted 
An. stephensi genes in transgenic Rel2-overexpressing (Dong et al. 2011) and WT 
mosquito lines at two time points following a blood meal in order to identify the Rel2-
driven changes in the midgut and fat body transcriptomes. Mosquitoes with Rel2 
expression driven by the midgut-specific carboxypeptidase promoter (CP line) were 
assayed at 6 and 12 h post-blood meal (PBM)), and samples with Rel2 expression driven 
by the fat body-specific vitellogenin promoter (VG line) at 12 and 18 h PBM. Selection 
of these time points was based on the recombinant Rel2 induction profile in the two 
tissues (Dong et al. 2011).  At 6 h PBM, there were 190 up-regulated and 94 down-
regulated genes in the midguts of CP line mosquitoes (Figure 2.3A), and these totals 
increased to 645 up-regulated and 596 down-regulated genes at 12 h (Figure 2.3A).  In 
VG line mosquitoes, there were 173 up-regulated and 152 down-regulated genes in the 
fat body at 12 h PBM and 203 up-regulated and 189 down-regulated genes at 18 h 
(Figure 2.3A).  This is similar to the number of differentially regulated genes seen in the 
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fat bodies of Rel2 overexpressing Ae. aegypti mosquitoes, which upregulated 123 and 
downregulated 176 downregulated genes following Rel2 activation (Zou et al. 2011).  A 
total of 71 transcripts were regulated by recombinant Rel2 activation in both the CP 
midgut and VG fat body, with 19 being regulated in the same direction at 12 h PBM (10 
up-regulated in both tissues and 9 down-regulated in both tissues) and 20 being up-
regulated in the midgut and down-regulated in the fat body; 32 displayed the opposite 
mRNA abundance pattern (Figure 2.3B).  It is unlikely that a transcription factor would 
up-regulate and down-regulate the same gene in different tissues, so it is much more 
likely that the differences in expression pattern are related to interactions with other 
transcription factors, feedback loops, or mRNA or protein degradation rates.  Because we 
were looking at global changes following Rel2 induction, we could not differentiate 
between an mRNA directly up-regulated by Rel2 and another that was down-regulated 
because of a silencing factor, or an mRNA with a long half-life compared to another that 
was degraded by a micro-RNA that was up-regulated by Rel2.   
Predicted gene ontology (GO) categories were assigned to genes based on homology to 
previously annotated An. gambiae genes (vectorbase.org). In both tissues and at all time 
points, the predicted GO category with the greatest number of significantly regulated 
genes was the diverse functional category (a total of 508 differentially regulated genes at 
12 h PBM) followed by the unknown category (328 total differentially regulated genes at 
12 hours PBM).  This is to be expected, since these two GO categories represent over half 
of the annotated genes in the An. gambiae genome (vectorbase.org), and therefore the 
predicted GO terms for our An. stephensi genes.  The broad functional spectrum of genes 




Figure 2.3: Global changes in transcript levels in transgenic A. stephensi following 
Rel2 induction. A) The total number of genes significantly up- or down-regulated that 
are predicted to be in each GO category.  Genes were considered significantly 
differentially regulated if the -fold change was>= 0.75 on a log2 scale.  B) Venn diagram 
comparing the total number of regulated transcripts between the midgut of CP line 
mosquitoes and fat body of VG line mosquitoes at 12 h PBM.  Red arrows correspond to 
midgut samples, and green arrows correspond to fat body samples; the arrow direction 
indicates significant up- or down-regulation. 
 
Because Rel2 is the major transcription factor of the IMD pathway, we conjectured that 
numerous genes assigned to the immune/apoptosis GO category would be up-regulated 
following Rel2 expression.  There were 26 genes from this category that were up-
regulated in the midgut of CP mosquitoes at 12 h PBM, representing 4% of the total up-
regulated genes at that time point. There were also 16 down-regulated genes in this 
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category at the same time.  In the VG line fat body, there were 36 up-regulated immune 
genes at 18 h PBM, representing 17.7% of up-regulated fat body genes at 18 h PBM, with 
12 down-regulated at the same time.  Highly up-regulated immune genes included both 
known anti-Plasmodium effectors, such as TEP1 and LRIM1 (Blandin et al. 2004, 
Povelones et al. 2009), and genes that have not yet been associated with Plasmodium 
resistance but that have shared domains with known anti-Plasmodium effectors, such as 
multiple leucine-rich repeat and fibrinogen domain-encoding genes and two MD-like 
genes (Riehle et al. 2008, Garver et al. 2009, Povelones et al. 2009).  While a smaller 
proportion of immune genes were found to be differentially regulated in the An. stephensi 
genome following Rel2 expression than in Ae. aegypti (Zou et al. 2011), many of the 
same types of immune genes are represented in the upregulated group, including thio-
ester proteins and proteins containing leucine rich repeats.  Representatives from other 
GO categories, such as serine proteases in the Proteolysis/Digestion group, redox 
responsive genes in the Redox/Stress/Mitochondrial category, and many others, are likely 
to be relevant for reciprocal interactions between Plasmodium and the mosquito.  Other 
up-regulated genes such as cytochrome P450s may play a role in the mosquito’s 
resistance to insecticides (David et al. 2013) and thereby affect the ability of these 
transgenic mosquitoes to survive and compete in the wild. 
 To determine changes in midgut and fat body proteomes following Rel2 
activation in these tissues, we used iTRAQ to quantify the relative amounts of all proteins 
in Rel2-overexpressing transgenic mosquitoes relative to their wild-type conspecifics 
both before and 24 h after a blood meal.  Filtering for only high confidence peptides, we 
identified 31,392 peptide spectrum matches (PSMs) corresponding to 8,574 peptides that 
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mapped to 2,244 unique protein contigs previously annotated by the Jake Tu Lab 
(Virginia Polytechnic Institute and State University). These proteins were assigned 
putative names and functions through a BLASTp search against the An. gambiae genome, 
yielding 2041 unique proteins, 2024 of which had significant similarity (BLASTp e-value 
<  0.01) to An. gambiae genes.  Prior to a blood meal, the transgenic mosquito midgut 
displayed significantly higher levels of 89 proteins and lower levels of 45 proteins.  The 
transgenic mosquito fat body displayed higher levels of 204 proteins and lower levels of 
31 proteins prior to the blood meal (Figure 2.4A).   One reason for the differential 
expression of these proteins in the absence of Rel2 induction may be that they may 
represent genes with permanently altered expression patterns, either as a result of position 
effects of transgenesis or adaptation during the numerous generations since the insertion 
of the transgene.  Alternatively, there may be leaky expression from the CP and VG 
promoters, as has been observed before for the VG promoter for some autogenous 
mosquito species (Provost-Javier et al. 2010), though not in Anopheles spp. mosquitoes. 
The reason for this leakiness could be further explained by examining the expression 
profiles of multiple lines with different transgene insertion locations.  However, due to 
the effort required to maintain these lines, only one line of each strain, with the most 
potent anti-Plasmodium activity, has been kept and therefore we are limited to observing 
the changes in a single line for each tissue.  As expected, at 24 h PBM, there were many 
more proteins displaying significantly altered abundances.  Specifically, after a blood 
meal there were 1,230 up-regulated and 64 down-regulated proteins in the midgut and 26 
up-regulated and 185 down-regulated proteins in the fat body (Figure 2.4A).  Of these, 
only 22 were significantly regulated in the same direction (10 up and 12 down) in both 
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the midgut and the fat body, while 78 were significantly regulated in opposite directions 
(77 up in the midgut and down in the fat body, and 1 with the reverse) (Figure 2.4B).  As 
with transcripts, the GO category with the greatest number of differentially regulated 
proteins assigned to it was the diverse category (493 total differentially regulated proteins 
at 24 h PBM), although all the GO categories were represented, especially in the list of 
proteins up-regulated in the midgut at 24 h PBM.    In the midgut, there were 50 proteins, 
or 4% of the total up-regulated proteins, belonging to the immune GO category that were 
significantly up-regulated at 24 h PBM, but there were only 2 significantly down-
regulated immune proteins, or 3.1%, at that time.  In the fat body at 24 h PBM, there 
were only 2 significantly up-regulated immune proteins, but these proteins represent 
7.7% of the total significantly up-regulated proteins, and there were 7 significantly down- 
regulated proteins representing 3.7%.  As for the transcriptome, there was a functionally 
diverse set of up-regulated immune proteins, including some corresponding to genes 
found to be regulated in the microarray–based transcriptome analyses, such as An. 
gambiae MD2-like protein 6 (AgMDL6) and neuronal leucine-rich repeat protein 3 
(NLRR3).  Other significantly up-regulated proteins were not found to be significantly 
up-regulated in the same tissue at the transcript level, but the regulated transcriptome and 
proteome sets contained many genes belonging to the same families, such as leucine-rich 
repeat and fibrinogen domain-containing proteins.  Interestingly, the levels of both Toll 
and Rel1, which are Toll pathway-associated genes, were significantly up-regulated at the 
protein level following Rel2 activation, possibly indicating an interplay between the IMD 





Figure 2.4: Global changes in protein levels in transgenic A. stephensi following Rel2 
induction. A) The total number of proteins significantly up- or down-regulated that are 
predicted to be in each GO category.  Genes were considered significantly differentially 
regulated if the ratio of transgenic to wild type was>= 0.75 on a log2 scale.  B) Venn 
diagram comparing the total number of regulated proteins between the midgut of CP line 
mosquitoes and fat body of VG line mosquitoes at 24 h PBM.  Red arrows correspond to 
midgut samples, and green arrows correspond to fat body samples; the arrow direction 
indicates significant up- or down-regulation.  
 
 In both the transcriptomic and proteomic analyses, we observed differential 
expression of genes belonging to various functional classes (Figures 2.3 and 2.4).  Here, 
we present a brief overview of the several classes of genes that we believe are relevant to 




 Immune-related genes:  In total, 102 separate immune-related genes were up-
regulated under at least one experimental condition, while 44 were down-regulated.  
These genes represent a large number of different families of immune genes, including 8 
leucine-rich repeat containing proteins, 5 tep proteins, 14 CLIP domain serine proteases, 
and 7 serine protease inhibitors, as well as many anti-microbial peptides and other genes.  
Interestingly, in addition to IMD pathway-associated genes such as Rel2, a number of 
Toll pathway-associated genes, including Toll and Rel1, were also significantly up-
regulated, indicating that there may be interaction between the two major immune 
pathways.  Similarly, Hop and JNK, components of the Jak/Stat and JNK pathways, were 
also up-regulated.  These data indicate that the various immune pathways do not act in 
isolation and may instead act together to attain a broader immune response.  The JNK 
pathway has recently been shown to play a role in Plasmodium resistance (Garver et al. 
2013), and interaction between the JNK and IMD pathways may lead to greater 
Plasmodium immunity.  Up-regulation of AMP genes such as defensin and cecropins 
likely plays a direct role in the control of bacteria and other pathogens (Meister et al. 
2005), and similar upregulation of AMP expression has been seen following Rel2 
induction in Ae. aegypti (Zou et al. 2011), while other genes such as the serine proteases 
likely trigger cascades to amplify and diversify the response (An et al. 2010). 
 Digestive: 485 digestion-related genes were up-regulated across the experimental 
conditions, and 280 were down-regulated.  Among these were genes involved in both 
protein and sugar digestion, as well as many Ras family proteins.  Numerous proteolysis 
related genes were also found to be differentially regulated in the Ae. aegypti Rel2 
regulated transcriptome (Zou et al. 2011).  Up-regulated protein digestion-related genes, 
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such as 26s proteosome subunits and serine/threonine phosphatases, work as part of the 
system for digesting blood meals following ingestion and may aid in the control of 
bacterial proliferation in the midgut following a blood meal.  Ras family proteins are 
GTPases involved in cell proliferation and signaling, some of which have been 
implicated in Drosophila immunity (Ye and Zhang 2013).  While evidence from 
Drosophila implicates the Ran subfamily of Ras genes in the phagocytosis of virus-
infected cells, other Ras genes may play a role in phagocytosis of other infectious 
organisms.  Alternatively, GTPases, such as Ras family proteins, and kinases may act in a 
similar fashion to serine proteases and related genes to amplify and diversify the signal 
from the IMD pathway.   
 Cell structure genes: There were also 82 up-regulated and 48 down-regulated 
genes in the Cell Structure GO category.  These included genes vital for muscle function 
or cell motility, such as 7 up-regulated and 3 down-regulated actins and 13 up-regulated 
and 8 down-regulated myosins; genes used for cell division, such as 3 up-regulated 
tubulins; and numerous cuticular proteins, actin- and chitin-binding proteins, and various 
other proteins.  Previous research has shown that the anti-Plasmodium immune response 
involves remodeling of the midgut epithelium (Han and Barillas-Mury 2002), as does 
bacterial resistance in the Drosophila midgut (Buchon et al. 2013).  In Drosophila, 
infected cells are expelled into the midgut lumen and must be regenerated, and both 
processes require action by the cell structure and motility system.  Other studies have also 
shown that remodeling of the cytoskeleton is necessary for successful Plasmodium 
infection and traversal of the midgut (Han and Barillas-Mury 2002), so changes in the 
cytoskeleton by the immune system may be important for resistance to infection. 
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 Redox genes: Finally, many redox and stress-related genes showed differential 
regulation.  Components of the ROS system have been implicated in resistance to both 
bacteria (Oliveira et al. 2011) and Plasmodium, and multiple NOS and mitochondrial 
carrier (Goncalves et al. 2012) genes are up-regulated following IMD pathway induction.  
The up-regulation of ROS-related genes by the IMD pathway may be a link between the 
various ways of fighting off midgut infection by both Plasmodium and bacteria.  By up-
regulating these genes, the mosquito can attack pathogens with both ROS and AMPs at 
the same time, increasing the potential for clearance.  Many components of the oxidative 
phosphorylation system, including various reductases and oxidases, were also up-
regulated under at least one condition, indicating that the mosquito may increase ATP 
production in order to compensate for energy use by the immune system.   
 Genes with few representatives: In addition to the gene families with large 
numbers of representatives listed above, there were also gene families with very few 
differentially regulated representatives.  For instance, odorant receptors and other sensory 
proteins were almost completely absent from the differentially regulated datasets, despite 
having many representatives in the genome (vectorbase.org).  Thus, the mosquito IMD 
pathway likely does not greatly affect the ability of mosquitoes to sense their 
environment.   
 While we have identified a large number of transcripts and proteins that displayed 
altered expression in our genetically modified mosquitoes following up-regulation of 
Rel2, not all of these genes are likely to be controlled directly by Rel2, and there are 
many Rel2-regulated genes that were not discovered through our approach.  We tested 
only a limited number of time points, and there may be short-lived transcripts and 
49 
 
proteins that were degraded before we collected our samples.  Similarly, some genes may 
take longer to transcribe and translate than others, and our time points may have been too 
early to observe the changes in expression.  Other genes may require the binding of 
different transcription factors not present in this study in addition to Rel2, and thus they 
would not be differentially regulated following the up-regulation of Rel2 alone.  
Conversely, some genes having promoter sequences with low affinity for Rel2 may be 
differentially regulated in our transgenic mosquitoes, likely because of the 
overabundance of an active Rel2 form in the system.  The differential regulation of many 
genes upon activation of recombinant Rel2 is also likely to represent a secondary effect 
and a general physiological response to immune activation. However, we believe that the 
time points we have chosen are well chosen to capture both the timing of Rel2 up-
regulation in our mosquitoes and the physiologically relevant times for P. falciparum 
invasion of the midgut, in the under-studied mosquito vector An. stephensi.  
 
2.3.2 Correlation between mosquito transcript and protein expression levels 
Because we measured both transcript abundance and protein abundance, we were able to 
compare the expression of genes at the two levels in order to assess a correlation between 
transcript levels and protein abundance.  Previous studies in other organisms have shown 
only weak concordance between transcripts and proteins (de Sousa Abreu et al. 2009, 
Vogel and Marcotte 2012), but such studies are usually restricted to unicellular organisms 
or cell lines, and this study provided an opportunity to expand this knowledge to 
multicellular eukaryotes.  
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When we looked at all the genes that displayed a significant difference at the 
protein abundance level at 24 h PBM and a significant difference at the transcript 
abundance level at one of the two time points, we saw no significant correlation between 
protein and transcript levels in the midgut when we used a linear model (Figure 2.5A). 
However, we saw a significant correlation for the fat body (Figure 2.5B). Our assays 
generated data for 1,273 genes at both the transcript and protein levels in the midgut, 240 
of which were significantly regulated in the same direction at both the protein and 
transcript levels, while 119 were significantly regulated in opposite directions.  In the fat 
body, we obtained data for 1,538 genes at both the transcript and protein levels, with 33 
significantly being regulated in the same direction at both protein and transcript levels 
and only 8 significantly regulated in opposite directions.  The lack of significant 
correlation between mRNA and protein levels in the midgut is likely due to the wide 
variety of genes that are differentially expressed in that tissue and the various post-
transcriptional modifications and regulatory mechanisms involved. The lack of 
correlation is also indicative of the large proportion of genes that are not directly 
regulated by the Rel2 transcription factor. Furthermore, factors such as transcript and 
protein degradation rates, miRNAs, mRNA secondary structure, the presence of other 
transcription regulators, and the availability of ribosomes and amino acids to build 
proteins could all contribute to differences between the abundance of mRNA and proteins 
(Maier et al. 2009, Vogel and Marcotte 2012).  For instance, if the mRNA of a particular 
transcript is quickly degraded but the protein is long-lived, or vice-versa, then an increase 
in the transcription of that gene will not necessarily lead to a measurable change in the 





Figure 2.5: Correlation between mRNA and protein levels in the mosquito midgut 
(A,B) and fat body (C,D) following a blood meal.  In the midgut there was no significant 
correlation between mRNA and protein levels whether looking at all genes (A, r
2
=0.0003, 
F-statistic = 0.4276, p-value = 0.5133) or only significantly regulated genes (B, r
2
=.0005, 
F-statistic = 0.1766, p-value = 0.6746), while in the fat body there was a significantly 
correlation both when looking at all genes (C, r
2
=0.02183, F-statistic = 34.28, p-value < 
0.001) and when looking at only significantly regulated genes (D, r
2
=0.3213, F-statistic = 
18.47, p-value < 0.001).  
 
regulators, including transcription factors, miRNAs, and feedback loops, may promote or 
inhibit transcription and translation differentially, leading to discordance between mRNA 
and protein levels.  Finally, it is possible that the time points at which we measured 
expression levels did not adequately capture the timing of gene expression. Our previous 
work indicates that Rel2 expression levels should be high at 12 h and remain elevated for 
many hours afterward in both the midgut and fat body, and protein levels would, if 
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directly governed by transcription, follow soon after.  An increase in transcripts, even if 
not immediately translated, could allow mosquitoes to increase the abundance of a 
protein quickly if other signals necessary for the translation of that gene were present.  
Similarly, differential degradation of transcripts and proteins may allow mosquitoes to 
remove unnecessary gene products, even if transcription is initiated by a promiscuous 
promoter.  Other studies have also shown a lack of correlation between mRNA and 
protein levels (You and Yin 2000, Gedeon and Bokes 2012).  Our results show that a lack 
of correlation between mRNA and protein expression levels is also prominent in 
mosquitoes, likely providing mosquitoes a fine level of control over the proteins 
expressed in their cells. 
 
2.3.3 Identification of novel anti-Plasmodium immune genes 
The analyses of transcript and protein abundance following Rel2 induction in transgenic 
mosquitoes allowed us to select a variety of genes to investigate further for involvement 
in the mosquito’s immune defense.  Because Rel2 is an IMD pathway-associated 
transcription factor, we expected a large number of significantly up-regulated immune 
genes.  Similarly, because this immune pathway is responsible for the mosquito’s 
resistance to Plasmodium infection (Garver et al. 2009), we were interested in identifying 
IMD pathway-regulated genes that control resistance to P. falciparum.  We began by 
selecting five of the immune genes with the greatest up-regulation at the protein level at 
24 h PBM in the midgut. We chose to consider only the protein level for these genes 
because it takes approximately 24 h for P. falciparum to exit the midgut lumen, so 
proteins with increased expression at this time will be available to act against the parasite.   
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 From the 20 most abundant immune proteins, we chose 5 that may have anti-
Plasmodium activity for further testing based on the level of up-regulation and predicted 
functions based on sequence homology. Specifically, we chose a class B scavenger 
receptor containing a SCRBQ1 domain (SCRBQ1), bacteria response protein 1 (AGBP1), 
Neimann-Pick type C-2 (NPC2), alpha-2-macroglobulin receptor-associated protein 
(A2MRAP), and a leucine-rich transmembrane protein (LRTP).  The selected genes were 
knocked down by RNAi prior to parasite exposure, and the resulting impact on P. 
falciparum infection of the mosquito midgut was assayed by oocyst counting (Figure 
2.6).  RNAi-based depletion of SCRBQ1, AGBP1, and NPC2 had no significant effect on 
Plasmodium infection levels; however, depletion of A2MRAP and LRTP led to 
significant increases in the number of oocysts per midgut (Kruskal-Wallis test, p<0.0001; 
Dunn's post-hoc test: A2MRAP, p<0.01; LRTP, p<0.001).   While the median number of 
oocysts was decreased following both A2MRAP and LRTP knockdown, none of the 
dsRNA treatments had a significant effect on oocyst prevalence, even though previous 
studies have shown that Rel2 knockdown by RNAi leads to an increase in oocyst 
prevalence. This difference in result may stem from the fact that the genes we knocked 
down are only a part of the whole immune response to Plasmodium infection, and their 
knockdown may not be efficient enough to affect the prevalence, whereas the full 
complement of IMD pathway-regulated immune effectors together cause a greater effect. 
 SCRBQ1 (ASTE009112/AGAP010132) is homologous to the Croquemort (CRQ) 
gene in D. melanogaster, which is essential for efficient phagocytosis of apoptotic cells 
in Drosophila embryos (Franc et al. 1996, Franc et al. 1999), and may play a role in anti-
Plasmodium defense through apoptosis or phagocytosis (Hurd et al. 2006, Blandin and 
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Levashina 2007).  AGBP1 (STE009712/AGAP008061) is one of a number of bacterial 
infection-responsive proteins that have been identified in An. gambiae,   and is up-
regulated following infection with P. berghei (Dong et al. 2006b).  However, P. berghei 
infection is principally controlled by the Toll pathway (Garver et al. 2009), so the 
relevance of this protein in defending against P. falciparum infection may be minimal.  
NPC2 (ASTE004995/AGAP002851) is a small, highly conserved, secreted protein that 
plays an important role in regulating sterol homeostasis in Drosophila (Ioannou 2007).  
Plasmodium parasites are unable to synthesize their own sterols and must scavenge these 
molecules from their host (Bano et al. 2007),so changes in the abundance of sterols may 
affect the ability of Plasmodium to infect mosquitoes.  NPC2 also plays an important role 
in dengue resistance of Ae. aegypti mosquitoes and may play a role in a variety of 
infection systems (Jupatanakul et al. 2013).  A2MRAP (ASTE011001/AGAP003521) is a 
protein associated with the receptor for alpha-2-macroglobulins.  Alpha-2-macroglobulin 
is an abundant protein that binds to a variety of ligands and is involved with the lectin-
dependant cytolytic pathway in arthropods (Armstrong and Quigley 1999).  The diversity 
of ligands to which alpha-2-macroglobulin can bind and its importance for the lysis of 
cells indicate that it, and its receptors, could be important for the lysis of Plasmodium 
infected cells and help mosquitoes fight off the parasite. Finally, LRTP 
(ASTE008359/AGAP007061) bears structural similarity to other proteins containing 
leucine-rich repeats.  Two such proteins, LRIM1 and APL1C, have been shown to be 
important for the anti-Plasmodium defense in An. gambiae (Dong et al. 2006b, Povelones 





Figure 2.6: P. falciparum infection intensity following RNAi knockdown of immune 
genes.  The number of oocysts per midgut of wild-type A. stephensi following RNAi-
mediated depletion of GFP, SCRBQ1, bacterial response protein (AGBP1), Niemann-
Pick type-C (NPC2), alpha-2-macroglobulin (A2MRAP), or leucine-rich transmembrane 
protein (LRTP).  Depletion of both A2MRAP and LRTP led to a significant increase in 
the number of oocysts per mosquito midgut.  Each circle represents a single midgut, and 
horizontal black bars represent the median of the sample.  Significance was determined 
by a Kruskal-Wallis test followed by Dunn's post-hoc test to compare immune-depleted 
mosquitoes to GFP controls.  Significance was assessed at α=0.05. Supplementary data 
for this figure is given in table 2.2. 
 
 The lack of an increase in Plasmodium oocysts per midgut following knockdown 
of SCRBQ1 is likely a result of gene redundancy, with alternative proteins also 
controlling apoptosis CRQ is largely expressed in the Drosophila embryo and not in 
adults, and it is possible that SCRBQ1 is similarly more active during mosquitoes' 
immature stages than in adults.  Both AGBP1 and NPC2 are known to be immune 
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modulators for other parasites and may simply display specificity for bacteria and viruses 
and not act against Plasmodium.  Knockdown of both A2MRAP and LRTP led to 
significant increases in Plasmodium infection, indicating that these proteins are important 
in modulating P. falciparum infection in the mosquito. 
 
2.3.4 Serine proteases affect mosquito anti-Plasmodium defenses  
A large number of proteases and digestive enzymes were highly up-regulated at both the 
protein and transcript levels.  Serine proteases and other proteolytic enzymes are often 
part of proteolytic cascades that can lead to the amplification of signals that control 
downstream effector mechanisms (An et al. 2010).   In mosquitoes, some serine proteases 
have been implicated in blood digestion (Yang and Davies 1971), the anti-Plasmodium 
defense (Volz et al. 2005, Blumberg et al. 2013), signal transduction, and many other 
diverse functions.  The TOLL immune pathway, for instance, is activated through a 
serine protease-dependent signaling cascade (Ligoxygakis et al. 2002, Weber et al. 2003).  
A number of serpins are involved in the prophenoloxidase (PPO) activation cascade, an 
important part of the innate immune system (Christophides et al. 2002, Ligoxygakis et al. 
2003, Weber et al. 2003), but the functions of many other serpins have yet to be 
elucidated.  The presence of many proteolytic regulators, including serine proteases and 
their inhibitors, in the highly up-regulated gene group at both the transcript and protein 
levels indicates that serine proteases play a role in the IMD pathway-based immune 
response and the mosquito anti-Plasmodium defense.  It may also help to explain the 
broad diversity of genes affected by increased expression of Rel2, since serine protease-
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dependent signaling cascades can both amplify and diversify the signal, causing changes 
in the regulation of many different genes. 
  Given the significant up-regulation of numerous proteases and related enzymes at 
both the protein and transcript levels, we decided to investigate a number of them further.  
Serine protease inhibitor 10 (SRPN10), Rel2-responsive serine protease 1 (R2RSP1), 
Rel2-responsive serine protease 2 (R2RSP2), serine protease precursor 1 (SEPRP1), 
trypsin precursor (TRYPP), angiotensin converting enzyme precursor (ACEP), and serine 
protease precursor 2 (SEPRP2) were all chosen because they showed at least a 2-fold 
induction at the transcript level at either 6 or 12 h PBM and at the protein level 24 h PBM 
in the midgut.  Silencing of R2RSP2, ACEP, and SEPRP2 significantly increased oocyst 
loads, suggesting that these factors are P. falciparum antagonists (Figure 2.7) (Kruskal-
Wallis test, p<0.0001; Dunn's post-hoc test for R2RSP2,  p<0.01, ACEP p<0.05, 
SEPRP2 p<0.001).  However, as with the immune genes, none of the silenced genes had 
a significant effect on oocyst prevalence.  Again, this may be due to the limited activity 
of only a few genes, when compared to the overall effects of the full IMD pathway-based 
response. Serine proteases act in diverse processes in mosquitoes and other dipterans, 
including activating signaling cascades (such as the Toll and PPO cascades) and 
regulating development.   SRPN10 (ASTE007248/AGAP005246) is one of many serine 
protease inhibitors (serpins) found in mosquitoes.  Studies in An. gambiae have shown 
that some isoforms of SRPN10 are up-regulated during the parasite’s traversal of the 
midgut and may be involved in anti-Plasmodium defense (Danielli et al. 2005).  R2RSP1 
(ASTE006240/AGAP007142) and R2RSP2 (ASTE014104/AGAP007165) are both 
examples of trypsin-like serine proteases.  SEPRP1 (ASTE009202/AGAP005065) and 
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SEPRP2 (ASTE010540/AGAP005310) are both precursors to serine proteases and may 
be involved in many of the same functions as R2RSP1 and R2RSP2.  TRYPP 
(ASTE010330/AGAP006709) is a precursor for a chymotrypsin which are proteolytic 
enzymes and form a subset of serine proteases that play a role in the digestion of 
mosquito blood meals (Yang and Davies 1971).  Serine proteases similar to those 
identified in this study cleave a variety of targets and may have many different functions, 
including the regulation of anti-Plasmodium activity.    Finally, ACEP 
(ASTE004060/AGAP004563) is a precursor for angiotensin converting enzyme (ACE), a 
family of proteins found in the hemolymph of insects and cleave a broad range of 
substrates (Riordan 2003, Burnham et al. 2005).  While various ACE-like proteins have 
been studied in An. gambiae and an immune function has been suggested, their potential 
effect on Plasmodium has not been investigated. 
Two serpins, SRPN6 and SRPN7, have previously been shown to play roles in the anti-
Plasmodium defense (Abraham et al. 2005, Blumberg et al. 2013), and we have identified 
a series of new serine proteases and precursors that also play a role in this defense.  
R2RSP2 is one of many mosquito serine proteases and may play a role in amplifying the 
immune signal.  Other serine proteases have also been shown to be vital for the 
melanization response in mosquitoes (Christophides et al. 2002), which can help to clear 
parasites; therefore, it is possible the R2RSRP2 increases melanization, although we have 
not measured this specific immune action.  While ACEs have not been shown to have a 
direct effect on Plasmodium infection in mosquitoes, it has been suggested that they can 
cleave immune-related substrates and thereby alter immune activity.  Our results 
demonstrate that ACEP has anti-Plasmodium activity in An. stephensi mosquitoes.   
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Figure 2.7: P. falciparum infection intensity following RNAi knockdown of protease 
genes.  The number of oocysts per midgut of wild-type A. stephensi following RNAi-
mediated depletion of: A) green fluorescent protein (GFP), serpin 10 (SRPN10), Rel2-
responsive serine protease 1 (R2RSP1), Rel2-responsive serine protease 2 (R2RSP2), or 
serine protease precursor 1 (SEPRP1); and B) trypsin precursor (TRYPP), anigiotensin-
converting enzyme precurser (ACEP), or serine protease precursor 2 (SEPRP2).  
Silencing of R2RSP2, ACEP, and SEPRP2 all led to significant increases in the number 
of oocysts per midgut.  Each circle represents a single midgut, and horizontal black bars 
represent the median of the sample.  Significance was determined by a Kruskal-Wallis 
test followed by Dunn's post-hoc test to compare immune-depleted mosquitoes to GFP 
controls.  Significance was assessed at α=0.05.  Supplementary data for this figure is 
given in table 2.2. 
 
Further investigation is needed to determine whether this activity is a direct or 
indirect effect.  Similarly, since SEPRP2 was identified as a precursor for an unknown 
serine protease, it is difficult to accurately predict all effects of altering the expression 
patterns of this gene, but, given the ability of serine proteases to act against Plasmodium 
discussed above, a precursor of any one of a number of serine proteases has the potential 
to be important for insect immunity.   
  
2.3.5 Effect of anti-Plasmodium effectors on midgut bacterial load 
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In order to determine whether the genes identified previously as having an anti-
Plasmodium effect act as general immune factors or are Plasmodium-specific, we tested 
them for involvement in controlling the mosquito midgut microbiota.  The mosquito 
midgut is colonized by a variety of bacteria that need to be tightly controlled to prevent 
overproliferation and damage to the insect host (Pumpuni et al. 1996, Straif et al. 1998).  
Many different bacterial strains can be present in the mosquito gut, and the community 
varies from mosquito to mosquito and species to species; however, Gram-negative 
bacteria are considered to make up the majority of the species (Straif et al. 1998).  
Previous studies have implicated the IMD pathway as the main pathway involved in 
controlling the levels of bacteria in the mosquito midgut (Dong et al. 2009).  Similarly, 
other studies have shown that the midgut microbiota is necessary to stimulate and prime 
the mosquito immune system and prepare it for future challenge (Dong et al. 2009, 
Clayton et al. 2012).  Some anti-Plasmodium factors also act against the midgut 
microbiota, while others do not. Therefore, we tested our newly identified anti-
Plasmodium effectors for an effect on the levels of bacteria in the mosquito midgut. The 
number of culturable bacteria per mosquito midgut was quantified by CFU assays 
following RNAi knockdown of potential novel anti-Plasmodium effector genes.  Thus, 
we tested A2MRAP, LRTP, R2RSP2, ACEP, and SEPRP2 for anti-bacterial effect in 
both sugar-fed and blood-fed mosquitoes.  In sugar-fed mosquitoes, one-way ANOVA 
showed a significant change in the log transformed number of colonies per midgut 
following knockdown of A2MRAP and LRTP (ANOVA p<0.05); however, a Dunnett's 
multiple comparison test showed no difference between either A2MRAP or LRTP and 
the GFP control, indicating that neither gene significantly affects midgut bacterial load  
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GFP CD-36 BRP NPC A2M LRTP
N 29 23 31 19 32 22
Range 0-114 0-88 0-148 0-108 0-191 0-127
Prevalence 75.86% 95.65% 97.10% 89.47% 93.75% 95.45%
Fisher's test 
p -value
0.0635 0.3271 0.2864 0.0723 0.1165
Median 9 11 21 15 56 71.5
% change 22.22% 133.33% 66.67% 522.22% 694.44%
Median no 
zeroes
18.5 12 31 16 63.5 73
GFP SRPN10 SERP42 SERP65 PREC65
N 127 142 111 126 120
Range 0-78 0-139 0-101 0-162 0-80
Prevalence 85.83% 81.69% 81.98% 92.06% 78.33%
Median 17 4.5 8 33 5
% change -73.53% -52.94% 94.12% -70.59%
Median no 
zeroes
22 14 15 38.5 10.5
GFP TRYP ANGI PREC10
N 111 66 100 113
Range 0-166 0-122 0-147 0-204




Median 6 4 22 35






0.4108 0.4795 0.1599 0.1367
 
Table 2.2: Supplementary data for Figure 2.6 and 2.7. Includes the number of 
mosquitoes assayed, the range, prevalence, median and % change in the number of 
oocysts per mosquito midgut. 
 
(Figure 2.8A).  The ANOVA revealed no significant differences between GFP, R2RSP2, 
ACEP, and SEPRP2 in sugar-fed mosquitoes (Figure 2.8B).  Following a blood meal, 
ANOVA revealed a highly significant difference in bacterial load between GFP, 
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A2MRAP, and LRTP (ANOVA p<0.0001), and a Dunnett's multiple comparison test 
showed a significant increase in bacterial load following knockdown of A2MRAP 
(Dunnett's p<0.001) (Figure 2.8C).  As with the sugar meal, there was no significant 
difference in bacterial loads after knockdown of GFP, R2RSP2, ACEP, or SEPRP2 after 
a blood meal (Figure 2.8D). 
 The fact that none of the five genes tested had any effect on culturable bacteria 
levels in the sugar-fed mosquito midgut may indicate that the midgut microbiota is 
somewhat stable at this point.  The midgut microbiota is adapted to the midgut 
environment and may therefore be able to evade action by various mosquito immune 
effectors. Alternatively, while multiple immune genes are able to affect the midgut 
microbiota, the genes we tested may display specificity for Plasmodium parasites and 
therefore not affect bacteria to a considerable degree.  Specificity in mosquito immune 
response is common, since even pathogens in the same genus, such as P. falciparum and 
P. berghei, elicit strikingly different immune responses (Garver et al. 2009), and infection 
by the two is controlled by separate immune pathways. Thus, it is likely that highly 
divergent pathogens such as Plasmodium and bacteria would also be affected differently. 
Similarly, we saw no effect of AGBP1 on Plasmodium infection, although it has been 
shown to have an effect on Staphylococcus aureus infection in the mosquito (Dong et al. 
2006b), adding credence to the theory of divergent immune action.   
Following a blood meal, only A2MRAP had an effect on bacterial load.  Blood 
meals have been shown in the past to have a large effect on the midgut microbiota of 
mosquitoes, leading to a large increase in the number of bacteria (Oliveira et al. 2011).  
This disturbance and proliferation may allow more opportunity for anti-bacterial genes to 
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take effect.  Alternatively, the expansion in bacterial numbers following a blood meal 
may allow for dangerous levels of bacteria in the midgut that need to be controlled by the 
immune system in order to prevent damage to the mosquito. Alpha-2-macroglobulins 
have relatively broad binding specificities (Riordan 2003), which may explain why this 
protein can act against divergent pathogens such as Plasmodium and bacteria.  
Alternatively, since A2MRAP is an alpha-2-macroglobulin receptor-associated protein, it 
may be able to bind to multiple different alpha-2-macroglobulin receptors and therefore 
have a broad specificity based on the different combinations of alpha-2-macroglobulins 
and their receptors.   
 Our findings support the hypothesis that the mosquito’s immune system is able to 
react in a specific manner to different pathogens, especially when they are distantly 
related. In addition, the fact that many more genes are up-regulated following Rel2 
induction in the midgut than in the fat body implies that mosquito immune pathways 
exhibit tissue specificity and that the IMD pathway may be more important for immune 
defense in the midgut than in the fat body.  The IMD pathway acts specifically against 
Gram-negative bacteria, which make up the majority of the mosquito midgut microbiota 
(Straif et al. 1998), and this pathway has been shown to be the major pathway involved in 
controlling the midgut microbiota in both mosquitoes and Drosophila.  The greater 
expression of IMD pathway-responsive genes in the midgut than in the fat body may 







Figure 2.8: Influence of novel anti-Plasmodium genes on midgut microbiota.  The 
number of colony forming units of culturable bacteria in the midguts of females 
following RNAi-mediated knockdown of genes shown above to have anti-Plasmodium 
effects.  A) Sugar-fed mosquitoes following depletion of GFP, A2MRAP, and LRTP. B) 
Sugar-fed mosquitoes following depletion of GFP, R2RSP2, ACEP, and SEPRP2.  C) 
Blood-fed mosquitoes following depletion of GFP, A2MRAP, and LRTP showed that 
A2MRAP depletion leads to a significant increase in CFUs per midgut.  D) Blood-fed 
mosquitoes following depletion of GFP, R2RSP2, ACEP, and SEPRP2.  Significance 
was determined by a one-way ANOVA, followed by Dunnett's multiple comparison test, 
with significance assessed at α=0.05.  Bars represent the mean of three biological 






In this work, we have measured the changes in expression, at both the transcript 
and protein level, in the midguts and fat bodies of P. falciparum-resistant, genetically 
modified mosquitoes that are transiently overexpressing the IMD pathway-regulated 
transcription factor Rel2 (Dong et al. 2011).  Through a combination of full-genome 
microarray-based expression analyses and iTRAQ proteomic analyses, we were able to 
see that specific up-regulation of Rel2 leads to differential regulation of a large number of 
both immune-related and other genes, including general immune genes and a large 
number of serine proteases cascade-related genes.  We measured the effect of knockdown 
of multiple immune genes including serine protease cascade-related genes on P. 
falciparum infection in mosquitoes, thereby identifying a number of novel genes 
implicated in anti-Plasmodium defense.  The presence of multiple serine proteases and 
their observed effect on Plasmodium infection indicate that these genes may be 
responsible for expanding and amplifying the IMD pathway signal and support the 
importance of serine proteases in the mosquito’s immune defense.  Of the five newly 
identified anti-Plasmodium genes, only one, A2MRAP, had an effect on the mosquito 
microbiota, and only after a blood meal.  Finally, by observing significant changes at 
both the transcript and protein levels, we were able to look for any correlation between 
transcript and protein levels.  In the midguts of our GM mosquitoes, we observed no 
correlation between the two, while in the fat body we saw a significant correlation, 
although many fewer genes were included in the fat body analysis.  The lack of a strong 
correlation between transcripts and proteins concurs with the results of other studies that 
have observed a similar lack of correlation, and it likely indicates a large role for post-
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transcriptional processing and control of translation, allowing mosquitoes to have a finer 
level of control over protein expression.  Overall, our results indicate that Rel2 has a 
significant impact on both the mosquito transcriptome and proteome. The patterns of 
differential gene expression in the fat body were similar to those seen in transgenic Ae. 
aegypti overexpressing Rel2 under the VG promoter, indicating that these pathways may 
be well conserved across mosquito species (Zou et al. 2011).  Also, as expected, we 
found that a number of genes controlled by the IMD pathway have an effect on anti-
Plasmodium defenses, while others have no known immune function.  This result 
indicates that the IMD pathway, and Rel2 specifically, controls or affects the expression 
of many non-immune processes.  By means of these effects, the mosquito’s immune 
response may be influenced by many factors that have not previously been considered to 
be part of canonical immune pathways.  Similarly, induction of the mosquito immune 
system may alter many non-immune processes that can have far-reaching implications for 
mosquito fecundity and fitness.  Overall, these results indicate that mosquito immune 
pathways act on a global level to produce complex changes in gene expression that will 
require further investigation to unravel fully.
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Chapter 3: The effects of genetic modification on An. stephensi fitness 
3.1 Introduction 
 Malaria is a global public health concern causing millions of cases each year and 
leading to hundreds of thousands of deaths, largely among children in sub-Saharan Africa 
(WHO 2014b).  The Plasmodium spp. parasites that cause malaria are vectored by 
various mosquitoes in the genus Anopheles, and control of these vector mosquitoes has 
been employed as part of many malaria control programs.  However, traditional vector 
control methods such as bed nets and insecticides have failed to bring about lasting 
changes in mosquito populations or reductions in malaria infection levels due to problems 
such as lack of compliance, difficulties in distribution and rising behavioral and 
physiological resistance in mosquito populations.  Therefore, novel vector control 
methods are constantly being investigated, such the release of transgenic mosquitoes with 
reduced vector competence or breeding capacity and the use of the endosymbiotic 
bacterium Wolbachia to reduce the ability of the mosquitoes to spread disease or the 
number of mosquitoes in an area, respectively (Dong et al. 2011, Bian et al. 2013).  
However, despite the creation of many mosquito lines with reduced vector competence in 
various laboratories, there have been no widespread releases of such mosquitoes as part 
of a coordinated malaria control program, in part due to our lack of knowledge about how 
genetic engineering of mosquitoes affects their fitness. 
 Mosquitoes possess an innate immune system capable of responding to various 
invading pathogens including bacteria, viruses and eukaryotic parasites.  This immune 
system comprises multiple pathways, such as the Toll and immune deficiency (IMD) 
pathways, which act to control different types of pathogens.  The IMD pathway is 
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responsible for mosquitoes' resistance to the human malaria parasite P. falciparum, and 
our lab has created multiple mosquito lines that transiently over-express the IMD 
regulated NF-kB transcription factor Rel2 following a blood meal (Garver et al. 2009, 
Dong et al. 2011).  One line, henceforth referred to as the CP15 line, up-regulates Rel2 in 
the midgut under the control of the carboxypeptidase promoter, while the other, 
designated the VG1 line, up-regulates Rel2 in the fat body under the vitellogenin 
promoter.  These mosquitoes show greatly increased resistance to P. falciparum infection 
in the laboratory with limited effect on their fitness (Dong et al. 2011). 
 Our laboratory has also created multiple transgenic mosquito lines that transiently 
over-express specific splice forms of the immunity-related hyper-variable Down 
syndrome cell adhesion molecule (AgDSCAM) (Dong et al. 2012).  The AgDSCAM 
gene can produce approximately 31,000 different splice forms that code for proteins with 
the ability to specifically bind to different substrates.  Some of the splice forms target 
specific pathogens and mediate immune defense to those pathogens, giving the mosquito 
an immune specificity not unlike our own antibodies, despite the lack of an adaptive 
immune system (Dong et al. 2006a).  Our laboratory has previously created mosquito 
lines transiently over-expressing both a long and a short form of P. falciparum specific 
AgDSCAM, containing the first 8 or 4 Ig domains, respectively, and has shown that they 
are highly resistant to P. falciparum infection (Dong et al. 2012).  These lines use the 
same CP promoter as the previously mentioned CP15 line of Rel2 over-expressing 
mosquitoes and have a similar expression pattern. In this study we tested two lines 
bearing the DSCAM short form, referred to as DsPfs3 and DsPfs11, and one line bearing 
the long form, referred to as DsPfL8. 
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 Despite the generation of Plasmodium resistant mosquito strains in both our 
laboratory and numerous others, no such mosquitoes have been released as part of a 
malaria control strategy.  One possible obstacle for the successful deployment of this type 
of genetically modified mosquito is that the genetically modified organisms may be less 
fit than their wild-type conspecifics (Marrelli et al. 2006). Furthermore, there is an 
assumption that over-activating insect immune systems will lead to a decrease in fitness.  
There is precedence for both of these assumptions, as earlier experiments in Drosophila 
have supported this, however mounting evidence indicates this is not the case.  Numerous 
early studies in Drosophila showed a negative fitness effect to immunity. Namely, 
infection with various bacteria and invasion by parasitoid wasps were shown to reduce 
fly lifespan, size and fecundity, especially in food limited conditions (Kraaijeveld et al. 
2002, Zerofsky et al. 2005, McKean et al. 2008). However, these studies on the effects of 
immunity on fitness were often based on infection with bacteria, which can cause effects 
independent of the immune up-regulation. Early studies on the effects of transgenic 
insects focused on constitutively expressed genes, and showed some negative fitness 
effects (Catteruccia et al. 2003, Irvin et al. 2004). However, more recent studies on the 
effects of genetic modification and immunity on insect fitness have used inducible 
promoters to up-regulate immune gene expression independent of many confounding 
factors (Dong et al. 2011). These recent studies have exhibited less of a fitness effect than 
previous studies, but the field remains convoluted (Dong et al. 2011, Smith et al. 2013b). 
 In order to determine the general effects of genetic modification on mosquito 
fitness, we tested the fitness of 5 genetically modified An. stephensi lines under a variety 
of conditions. By testing these different lines we were able to compare effects due to 
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different inserts, different promoters and different insertion sites, making this a general 
study of the effects of genetic modification on mosquito fitness. 
 
3.2 Materials and Methods 
Mosquito Rearing 
Wild-type An. stephensi (Liston) and transgenic mosquitoes of the CP15, VG1, DsPfs3, 
DsPfs11 and DsPfL8 lines were reared according to standard insectary conditions (Dong 
et al. 2011, Dong et al. 2012). Briefly, larvae were reared at low densities and fed a 
combination of ground fish flakes (Tetra) and cat food pellets (Purina). Upon emergence, 
adults were maintained on a 12h:12h light:dark cycle at 27º C with 80% humidity and 
provided constant access to a 10% sucrose solution in water, unless otherwise described 
for experimental conditions. To stimulate egg production, mosquitoes were provided a 
human blood meal from artificial membrane feeders on warmed water bottles. 
Genetically modified mosquitoes were screened for eye fluorescence each generation to 
ensure that all experimental mosquitoes bore the genetic modification. 
 
Lifespan and Fecundity Measurements 
In order to measure the lifespan of the various mosquito lines, adult mosquitoes were 
placed into cups within 12 hours of emergence. They were then held there until all 
mosquitoes died and the number of dead mosquitoes in the cup was recorded daily.  For 
standard lifespan assays, mosquitoes were provided a sugar meal upon emergence and 
maintained until death. Mosquitoes were offered a blood meal 7 days after emergence for 
the single blood meal group, and at 7, 14 and 21 days after emergence for the multiple 
blood meal group. For both the single blood meal group and the multiple blood meal 
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group, only mosquitoes taking a blood meal at day 7 were kept for the rest of the study, 
while in the multiple blood meal group mosquitoes were kept even if they did not take a 
blood meal at days 14 and 21 post emergence. For starvation conditions, mosquitoes were 
allowed to emerge, provided a sugar meal for 3 days, then starved of sugar, but constantly 
provided a water soaked pad. For the blood fed group, on day 3 post emergence the 
mosquitoes were provided a human blood meal from artificial membrane feeders prior to 
starvation, while no such meal was provided for the sugar fed group. For mosquitoes kept 
at lower temperatures, the mosquitoes were reared as usual, but upon emergence the 
mosquitoes were moved to a 19º C chamber and maintained with constant access to a 
10% sucrose solution until all mosquitoes had died. As with the standard conditions 
group, blood meals were provided for the applicable groups at days 7, 14 and 21 days 
post emergence. In all cases, once per week the dead mosquitoes were removed from the 
cups. 
 To measure fecundity, mosquitoes were reared under standard conditions and 
provided a blood meal 3 days post emergence. Mosquitoes were knocked down on ice 
immediately following the blood meal and any non-engorged mosquitoes were discarded. 
Two days after the blood meal, female mosquitoes were separated into individual vials 
containing moist filter paper and allowed to oviposit, and the number of eggs laid by each 
female was recorded. Only females that successfully took a blood meal during the first 
feeding and the second feeding were used for assays involving multiple blood meals. 
Following individual egg laying, eggs from the first blood meal were assayed for larval 
hatch rate, development time and male:female ratio. Eggs were hatched in trays as usual 
and the number of larvae recorded during the second instar. Larvae were maintained at 
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low density and the number of pupae present on each day was recorded to determine 
development time. Upon emergence, the number of male and female mosquitoes was 
counted. 
 
Wing length  
Adult wing length was used as a surrogate measurement for mosquito size.  Wings were 
cut off 3 days post-emergence and placed on double sided tape on microscope slides. 
Pictures of wings were taken through a microscope objective containing a scale bar 
calibrated to a 1mm stage micrometer and measured using ImageJ.  
 
Blood meal consumption 
To measure the amount of protein consumed during a blood meal, a standard Bradfrod 
Assay was used. Mosquitoes were provided a human blood meal from artificial 
membrane feeders and allowed to feed for 30 minutes. At that time, the mosquitoes were 
immediately placed into a freezer and maintained at freezing temperatures until dissected. 
Mosquito midguts were dissected in sterile PBS and placed into tubes containing 50 ul of 
hypotonic buffer (5 mM Tris, 0.1 mM MgCl2, 1 mM DTT, Protease inhibitors) with 1% 
triton. The midguts were then ground with a motorized pestle and incubated on ice for 30 
minutes. The lysate was then put through two freeze/thaw cycles and spun at 15,000 g for 
20 min at 4° C and 5 ul of the cleared lysate was added to 495 ul of 1x Quick-Start 
Bradford dye reagent (Bio-rad) and incubated at room temperature for 15 minutes. At this 
time, the samples were measured using a spectrophotometer and the amount of protein 
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recorded. Blood fed midguts were compared to the average of 10 unfed midguts, giving 
the amount of protein taken during a blood meal. 
 
Recombinant insert location mapping 
In order to determine the point at which the constructs inserted into the mosquito 
genome, a modified version of splinkerette PCR was performed, according to the 
modifications made in Smith et al. 2013 (Potter and Luo 2010). Briefly, genomic DNA 
from larval mosquitoes was cut with restriction enzymes and adapter sequences were 
ligated on. Two rounds of nested PCR using primers specific to the adapters or piggybac 
followed, and the PCR products were cloned into topoTA vectors and sequenced. The 
resultant sequences were located in the An. stephensi genome via a blast search and 
confirmed via PCR. PCR primers used are found in table 3.1. 
 
Cage Competition Trials 
To determine whether genetically modified mosquitoes are able to compete with their 
wild-type conspecifics, cage competition trials were set up. First, 50 wild-type and 50 
genetically modified larvae were combined during the second instar and allowed to 
develop and emerge as usual.  Upon emergence, the adult mosquitoes were maintained on 
either 10% sucrose (septic) or 10% sucrose with 100 units/mL of penicillin, 100 ug/mL 
of streptomycin and 75 ug/mL of gentamycin to remove their native midgut microflora 
(aseptic). Three days post-emergence, the adult mosquitoes were provided a human blood 
meal from artificial membrane feeders and allowed to oviposit. The resultant eggs were 
hatched and the proportion of transgenic larvae was recorded. To ensure that there were  
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Splink 1 splinkerette CGAAGAGTAACCGTTGCTAGGAGAGACG 
Splink 2 splinkerette GTGGCTGAATGAGACTGGTGTCGAC 
pBac LE 1 splinkerette CAGTGACACTTACCGCATTGACAAGC 
pBac LE 2 splinkerette GCGACTGAGATGTCCTAAATGCAC 
pBac RE 1 splinkerette CGATATACAGACCGATAAAACACATGCGTC 
pBac RE 2 splinkerette ACGCATGATTATCTTTAACGTACGTCAC 
CP15 F GM testing GTCGGCAAGGCTAAAGGAAC 
CP15 R GM testing CGGTTCGGTCTTTAGTGTTAAGG 
VG1 F GM testing CCACGGAAGCGTTAATGAGT 
VG1 R GM testing GAGAGCGCGTTATTGTGTGA 
DsPfs3 F GM testing CAAACGAGCAAGGAGACCTATATG 
DsPfs2 R GM testing TGAGCTACTACGCTCCTAATCATG 
DsPfs11 F GM testing GCTTCCGACGAAGTGGTAGA 
DsPfs11 R GM testing AGCAGTTCGAATGGGTTCAC 
DsPfL8 F GM testing CAATCGGATACCACAAATGTCCAG 
DsPfL8 R GM testing CTCCATGACGCACATTCCTATTC 
 
Table 3.1: PCR primers used in this study. "Gene name" displays the name of the gene 
targeted by the primer, "Primer type" indicates whether this primer was used for 
splinkerette PCR or detection of the insert in the mosquitoes and "Primer sequences" 
gives the sequences the primers. 
 
no confounding effects of the mosquito larval population, the same experiment was set up 
except that the mosquitoes were reared at low densities and adults were allowed to 
emerge individually in the wells of a 24 well plate. These virgin adults were then 
combined in a ratio of 25:25:25:25 genetically modified males:genetically modified 
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females:wild-type males:wild-type females.  Again, the mosquitoes were provided 
sucrose with or without antibiotics, provided a blood meal and allowed to oviposit, and 
the proportion of genetically modified mosquitoes was recorded at the larval stage of the 
next generation. 
 To determine whether the results of the initial breeding continued through 
multiple generations, the larvae from the two most successful lines (CP15 and DsPfs3) 
were allowed to develop to adulthood and maintained for 10 generations. Each 
generation, the proportion of genetically modified larvae was recorded and only 100 
larvae were kept until the next generation in the same proportion as the total population. 
All larvae were allowed to develop to adulthood, and three days after the emergence of 
the last adult the mosquitoes were provided a human blood meal from artificial feeders, 
allowing the population to continue under Hardy-Weinberg equilibrium assumptions. At 
the 10
th
 generation after the initial cross, the mosquitoes were separated at the larval into 
wild-type or genetically modified larvae and allowed to develop into adults. These adults 
were provided a P. falciparum infectious blood meal, as described below, to determine 
their resistance to the parasite. 
 
Insemination studies 
To measure whether genetically modified males and wild-type males differ in their ability 
to inseminate females, 5 virgin genetically modified males and 5 virgin wild-type males 
were placed into a cup with 10 virgin wild-type females and provided sucrose with or 
without antibiotics, as described above. Three days later, the females were provided a 
blood meal and allowed to oviposit. The number of eggs per female was recorded, and 
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the eggs were hatched to determine whether the female was inseminated by a wild-type 
or genetically modified male. Any females that did not lay eggs were dissected in sterile 
PBS and their spermatheca removed for testing via PCR according to the procedures 
described in (Rogers et al. 2009).  PCR primers are listed in table 3.1. 
 
P. falciparum infections 
To determine mosquito resistance to P. falciparum infection, mosquitoes were given 
infectious blood meals containing gametocytes from the NF54, HL1204 or 7g8 strain of 
P. falciparum. Mosquitoes were provided a blood meal of human blood containing the 
parasites from artificial membrane feeders and allowed to feed for 30 minutes before 
being maintained under standard conditions until dissection. 8 days after infection, 
mosquitoes were dissected in sterile PBS and their midguts stained with mercurochrome 
and the number of oocysts per midgut counted visually via light microscope. 
 
Colony forming unit assays 
To determine the number of culturable bacteria in the mosquito midguts, colony forming 
unit (CFU) assays were performed according to standard procedures. Briefly, adult 
mosquitoes were surface sterilized in 70% ethanol for 2-3 minutes, rinsed twice in sterile  
PBS and dissected in sterile PBS. Midguts were dissected out and placed into 150 ul of 
sterile PBS on ice, then ground with a mortar and pestle for 1 minute. The resultant 
solution was plated onto LB agar plates at 1:1 and 1:100 dilutions and allowed to grow at 
room temperature for 3 days, at which time the number of bacteria per plate was counted, 
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giving the number of bacteria per midgut. Dissections were performed prior to and 2 days 
post-blood meal, indicating the times when mating and oviposition occur, respectively. 
 
O'nyong'nyong infections and plaque assays 
GFP expressing O'nyong'nyong virus (ONNV) was obtained from the Foy lab. Frozen 
virus stocks were added to baby hamster kidney (BHK) cells and allowed to develop for 
48 hours. At this point, 83 ul of the supernatant from the cell culture was added to 417 ul 
of human blood and provided as an infectious meal to 3 day old adult mosquitoes.  5 days 
after feeding, blood-fed mosquito midguts were dissected in sterile PBS and ground in 
150 ul of DMEM containing 10% FBS and 110 units/mL of Penicillin and 110 ug/mL of 
streptomycin. These samples were used for plaque assays according to standard 
procedures, and the number of plaque forming units (PFUs) per midgut was recorded 7 
days after plating.  
 
Insecticide resistance testing 
To measure the susceptibility or resistance of the mosquitoes to various insecticides, a 
standard World Health Organization (WHO) tube assay was performed, according to 
standard procedures. Supplies and insecticide-treated papers were obtained from the 
WHO. 3 day old adult mosquitoes were provided a human blood meal from artificial 
membrane feeders and tested for resistance to insecticides 1 hour post-blood meal. 25 
blood fed adult females were exposed to each insecticide for 1 hour, and the number of 




Wolbachia infected mosquito crosses 
To test whether Wolbachia based malaria control strategies are compatible with our 
genetically modified mosquitoes, we crossed the genetically modified lines with the 
Wolbachia infected LB1 line from Zhiyong Xi (Bian et al. 2013). Because the lines are 
from the same background, we did not perform any backcrosses and tested the P. 
falciparum resistance in the offspring of the initial crosses. Three day old adult females 
were challenged with P. falciparum as described above. 
 
3.3 Results and Discussion 
3.3.1 Lifespan and fecundity 
 The lifespan of genetically modified An. stephensi strains were measured under a 
variety of different conditions for both female and male mosquitoes. Adult female 
mosquitoes subsist on nectar from various sources between blood meals, though the 
importance of these sugar meals is debatable. Therefore, we first tested the lifespan of 
female mosquitoes fed only on sugar (Figure 3.1A).  When provided with a constant 
source of 10% sucrose but no blood meal, there was no difference in lifespan for any 
other mosquito strains tested. However, female mosquitoes that feed on only sugar cannot 
reproduce and are unable to spread malaria. Therefore, we performed similar experiments 
with mosquitoes provided with a blood meal (Figure 3.1B). Again, we observed no 
difference in the longevity of mosquitoes after being provided a blood meal seven days 
post emergence. Again, however, mosquitoes that take only one blood meal are unable to 
spread malaria, so we repeated the experiments a third time, this time providing the 
mosquitoes three separate blood meals, one every seven days (Figure 3.1C).  When 
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provided three blood meals, female mosquitoes of the DsPfs11 line lived a significantly 
shorter period of time than wild-type females. Male mosquitoes only feed on sugar, as 
they do not need the protein provided by a blood meal to reproduce. Therefore, we tested 
the longevity of male mosquitoes only when provided with a sugar meal.  As with 
females taking multiple blood meals, only DsPfs11 strain mosquitoes exhibited a 
significant decrease in longevity compared to wild-type  mosquitoes (Figure 3.1D). 
Because DsPfs3 and DsPfs11 mosquitoes were generated using the same insert, but a 
fitness cost was only observed in the DsPfs11 strain, it is unlikely that the inserted gene is 
the cause of the effects. 
 Early experiments on genetically modified insects showed a marked reduction in 
lifespan (Catteruccia et al. 2003, Irvin et al. 2004). However, these experiments were 
based on insects with constitutively expressed transgenes, while our mosquitoes have 
transient induction of the transgene under blood-meal inducible promoters (Dong et al. 
2011, Dong et al. 2012).  Other groups have found similar results using inducible 
promoters, indicating that temporally restricted expression of genes may generally not 
cause a lifespan reduction in insects (Marrelli et al. 2007, Smith et al. 2013b). However, 
the fact that we observed a decrease in lifespan in one strain under certain feeding 
conditions indicates that it is important to test genetically modified mosquitoes, or other 
insects of interest, under a variety of conditions. If genetically modified organisms are 
only tested under one set of conditions, a potential fitness effect may not be observed.  A 
decrease in lifespan could help or hinder the effectiveness of a genetically modified 
mosquito line. On the one hand, a lifespan reduction could make it harder for a mosquito 





Figure 3.1: Lifespan of genetically modified mosquitoes. Female mosquitoes were fed 
on: A) sugar only B) sugar with a blood meal at 7 days post eclosion or C) sugar with 3 
blood meals at 7, 14 and 21 days post eclosion, and the number of dead mosquitoes was 
recorded each day, as were D) male mosquitoes. There was no difference in the lifespan 
of genetically modified female mosquitoes fed on sugar only or provided only 1 blood 
meal when compared to wild-type mosquitoes of the same feeding status, however 
DsPfs11 females provided with 3 blood meals and DsPfs11 males lived a significantly 
shorter period of time than wild-type mosquitoes. All figures represent the pooled data 
from 3 separate replicates of 25 mosquitoes compared using a log-rank test with a = 0.05, 
and * indicates a significant difference in lifespan compared to wild-type mosquitoes. 
Vertical red lines indicate the days of blood feedings.  
 
opportunities it has to lay eggs, which increases the population of mosquitoes. Therefore, 
if genetically modified mosquitoes die sooner, they may not be able to reproduce as many 
times, thereby laying fewer eggs and decreasing their ability to invade the population. 
Similarly, the fact that males dies sooner may give them fewer opportunities to mate, 




ability of the genetically modified mosquitoes to replace their wild-type conspecifics.  
Conversely, a slight reduction in lifespan might not be sufficient to influence mating 
success in a significant fashion while further reducing the vectorial capacity of the 
mosquitoes. Because mosquitoes must live past the extrinsic incubation period before 
they can pass infectious parasites to the next host through their saliva, if they die sooner 
they may not have the opportunity to infect any humans. This effect would compound the 
decrease in vector competence caused by the genetic modification, making them more 
effective as a malaria control tool (Macdonald 1957). Nevertheless, whether the lifespan 
reduction decreases, increases or has no effect on the effectiveness of genetically 
modified mosquitoes as a tool for malaria control would have to be elucidated in the 
field.  
 Mosquitoes in the laboratory are provided with a constant source of sucrose, but 
this is not the case with mosquitoes in the wild.  Sugar sources are widely dispersed and 
may be hard for mosquitoes to find, so we also tested the longevity of genetically 
modified mosquitoes when starved.  Neither female mosquitoes provided with only sugar 
meals prior to starvation nor female mosquitoes provided a blood meal prior to starvation 
showed a significant difference in lifespan compared to wild-type mosquitoes for any 
strain (Figure 3.2). Again, this illustrates that it is important to test genetically modified 
organisms under a wide variety of conditions to ensure that any extant fitness costs are 
observed. In the field, mosquitoes may experience starvation conditions during the dry 
season or when plants are not abundant. As with a general lifespan reduction, the effect 
of this on the genetically modified mosquitoes' effectiveness as a malaria control tool 




Figure 3.2: Lifespan of genetically modified mosquitoes when starved. Female 
mosquitoes were fed on: A) sugar only or B) a blood meal 3 days post eclosion before 
being starved and provided only water. The number of dead mosquitoes was recorded 
each day. There was no difference in the lifespan of female genetically modified 
mosquitoes compared to wild-type, regardless of whether they were provided a blood 
meal prior to starvation or not. Both figures represent the pooled data from 3 separate 
replicates of 25 mosquitoes compared using a log-rank test with a = 0.05. 
 
mosquitoes were released, it could stop them from invading the population and make 
them less effective. However, if the mosquitoes were able to replace the wild-type 
population before starvation ensued, a decreased lifespan could cause a decrease in 
mosquitoes surviving past the extrinsic incubation period, as well as decreasing the total 
number of mosquitoes in the area, increasing the effectiveness of the control program. 
However, our mosquitoes showed no reduction in lifespan, indicating that there would be 
no effect of starvation on the effectiveness of our genetic modifications on malaria 
control.  
 Starvation is not the only adverse condition mosquitoes may face in the field. The 
mosquitoes in our insectary are maintained at a constant temperature of 27º C, while 
mosquitoes in the field may encounter a variety of temperatures. We, therefore, also 
tested mosquito lifespan at 19º C to see if their lifespan is affected by the lower 
temperature. Female mosquitoes, whether provided only sugar, one blood meal or 
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multiple blood meals, did not show a significant effect of temperature on lifespan, while 
male mosquitoes of the DsPfs11 strain did show a decreased lifespan at the lower 
temperature (figure 3.3). Temperature can have a profound effect on both the mosquito 
and the Plasmodium parasite, as temperature affects both the vector and the development 
time of the parasite in the mosquito (Blanford et al. 2013, Christiansen-Jucht et al. 2014, 
Murdock et al. 2014).  The decreased survivorship observed in males could result in 
reduced mating capacity under adverse conditions, limiting the ability of this strain to 
invade wild-type populations. However, none of the other strains had any observable 
difference at this temperature, indicating that their ability to replace wild-type 
populations will not be adversely affected by lower temperatures. However, this study 
only considers populations held at a constant temperature, which is not the case in the 
field. Natural temperatures fluctuate through and between the days, and further 
experiments should be conducted under variable temperature conditions (Murdock et al. 
2012). 
 The lifespan of mosquitoes is only one measure of their success. Additionally, the 
mosquitoes must be able to lay viable eggs and the resultant larvae must develop into 
adults for the mosquitoes to continue on to the next generation. Therefore, any 
genetically modified mosquitoes intended for field release must not be deficient in these 
areas in order to be successful. We measured the number of eggs laid by each strain of 
mosquito, along with the hatch rate, larval survival, development time and proportion of 
offspring that were female. When provided with only one blood meal, there was no 





Figure 3.3: Lifespan of genetically modified mosquitoes at 19º C. Female mosquitoes 
were held at 19º C and fed on: A) sugar only B) sugar with a blood meal at 7 days post 
eclosion or C) sugar with 3 blood meals at 7, 14 and 21 days post eclosion, and the 
number of dead mosquitoes was recorded each day, as were D) male mosquitoes. There 
was no difference in the lifespan of female mosquitoes, regardless of feeding status or 
strain, however DsPfs11 males lived a significantly shorter period of time than wild-type 
males. All figures represent the pooled data from 3 separate replicates of 25 mosquitoes 
compared using a log-rank test with a = 0.05 and * indicates a significant difference in 
lifespan compared to wild-type mosquitoes. Vertical red lines indicate the days of blood 
feedings. 
 
after taking a second blood meal DsPfs11 females laid significantly fewer eggs than wild-
type females, while all other strains remained the same (Figure 3.4B). The same insert 
was used to create the DsPfs3 line, which had no such effect, indicating that these fitness 
costs, as with the lifespan effects exhibited by the DsPfs11 line, are not due to the 
construct itself. Following egg laying, the same proportion of eggs hatched for all tested 





Figure 3.4: Fecundity of genetically modified mosquitoes. Female mosquitoes were 
provided A) 1 blood meal at 7 days post eclosion or B) two blood meals at 7 and 14 days 
post eclosion, and the number of eggs laid by individual females was counted after each 
feeding. The eggs from the first egg laying were hatched and C) the percentage of eggs 
hatching was recorded as was D) the development time of the resultant larvae and E) the 
sex ratio of the adults emerging from those larvae. There was no difference in the number 
of eggs laid after the first blood meal between any of the genetically modified mosquito 




than their wild-type conspecifics following the second blood meal. There was also no 
difference in the egg hatch rate, development time or sex ratio between the strains tested 
here. All figures represent the pooled data from 3 separate replicates of the offspring 
from 10 mosquitoes compared using a Kruskal-Wallis test followed by a Dunn’s post-hoc 
test (A, B, C, E) or a log-rank test (D) using a-0.05 and * indicates a significant 
difference in the number of eggs laid compared to wild-type mosquitoes. 
 
development time either Figure (3.4D), nor was there a difference in the proportion of 
mosquitoes from each strain that were female or male (Figure 3.4E). Taken together, 
these data suggest that there is no significant difference in any of the main reproductive 
factors that we measured for any strain other than DsPfs11. 
 The reduction in the number of eggs laid by the DsPfs11 mosquitoes will severely 
limit their ability to replace wild-type mosquito populations. While some models have 
predicted complex interactions between larval population size and adult population size, 
it is generally believed that a reduction in the number of eggs laid will lead to fewer 
adults (Couret et al. 2014, Wasserberg et al. 2014). This means that there will be fewer 
genetically modified mosquitoes hatching, and therefore that the genetically modified 
mosquitoes will not replace the wild-type mosquito population. However, the other 
mosquito strains exhibited no such decrease in fecundity, indicating that they should be 
able to compete with wild-type mosquitoes, and that they may, therefore, be useful for 
malaria control programs.  
3.3.2 Size and blood meal consumption 
One factor that affects the ability of mosquitoes to mate and reproduce is their size 
(Sawadogo et al. 2013, Maiga et al. 2014). Larger females are able to lay more eggs and 





Figure 3.5: Size of genetically modified mosquitoes. The wing lengths of A) female 
and B) male adult mosquitoes were measured under a microscope using a micrometer. 
There is no difference in the length of wings from either female or male mosquitoes of 
any tested genetically modified strain compared to wild-type mosquitoes. Both figures 
represent the pooled data from 3 separate replicates of 5 mosquitoes compared using a 
Kruskal-Wallis  test with a-0.05. 
 
wing beat frequency to mate, and wing size affects the possible set of frequencies a 
mosquito can create, thereby affecting their mating success (Cator et al. 2009). To 
determine whether genetically modified mosquitoes were as large as wild-type 
mosquitoes, we measured the wing size of adult mosquitoes three days after emergence. 
There was no difference in wing size among and of the tested strains, which corroborates 
the previously observed data in which we saw no significant difference in fecundity 
between most of the strains. While the DsPfs11 strain did not have a difference in wing 
length in either males or females, they were not able to lay as many eggs. This, however, 
may be a post-mating effect, whereas wing length would cause a pre-mating effect.  
However, mate choice among mosquitoes is a complex and poorly understood system, 




Figure 3.6: Amount of protein ingested during a blood meal by genetically modified 
mosquitoes. The amount of protein consumed by adult female mosquitoes in a blood 
meal take 3 days post eclosion was measured by a Bradford assay. There is no difference 
in the amount of blood protein consumed by genetically altered female mosquitoes 
compared to wild-type females. The figure represents the pooled data from 3 separate 
replicates of 5 mosquitoes compared using a Kruskal-Wallis  test with a=0.05. 
 
Female mosquitoes of the Rel2 over-expressing CP15 and VG1 lines have been 
shown previously to differentially regulate a large number of different genes compared to 
wild-type mosquitoes, including many not connected to the canonical immune pathways 
(Pike et al. 2014). This large and varied up-regulation could lead to a fitness cost due to 
the energy required to transcribe and translate the numerous genes. However, the data 
presented so far have not supported this. One potential reason for this would be additional 
energetic intake by taking a larger blood meal. We used a Bradford Assay to measure the 
amount of protein taken in during a blood meal in all of our mosquito strains. 
Standardizing blood fed midguts to the midguts of sugar fed mosquitoes and comparing 
between strains showed no difference in the amount of protein taken up by any of the 
genetically modified strains when compared to wild-type mosquitoes (Figure 3.6). The 
lack of a difference in the amount of protein taken up during a blood meal may partially 
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explain the lack of noticeable fitness consequences in most of our genetically modified 
lines. Because mosquitoes immediately after a blood meal have an abundance of proteins 
available and tend to rest while digesting the blood, any increased expression of genes 
may be offset by the abundance of energy available and lack of energy used for other 
activities, such as flying (Chang et al. 2008). Along with this, due to the blood meal 
inducible promoters used to drive transgene expression in our mosquitoes, the expression 
of the genetic modifications in our mosquitoes are very short term, so by the time the 
excess energy from the blood meal is expended, the expression has already returned to 
baseline. Therefore, while there may be greatly increased energy expenditure due to the 
genetic modification, the increased availability of proteins and energy may offset this 
expenditure. 
 
3.3.3 Recombinant insert location mapping 
 One possible explanation for the large fitness cost observed in DsPfs11 
mosquitoes and simultaneous lack of any observable fitness cost in DsPfs3 mosquitoes 
containing the same insert in a different location is position effects. These are effects on 
the expression or operation of genes due to an insertion happening in or near a gene or 
regulatory sequence. To determine whether position effects are the cause of the negative 
fitness effects in the DsPfs11 line we used splinkerette PCR to determine the insertion 
points of all the genetically modified mosquitoes strains (Potter and Luo 2010, Smith et 
al. 2013b). In three of the four lines that exhibit no fitness cost, the cassette did not insert 
near an annotated mosquito gene, while in DsPfs11 mosquitoes the genes inserted 2 
kilobases bases downstream of a predicted cadherin gene. Cadherins are calcium 
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dependent adhesion molecules, and have been shown to be important in cell-cell 
interactions and adherence, as well as mosquito resistance to bacterial toxins, including 
the cry toxins of Bacillus thuringiensis. Therefore, disruption of the expression of this 
gene may cause dysfunction in cell-cell signaling, adherence or bacterial resistance, 
causing the observed fitness cost. Interestingly, the cassette of genes in the VG1 
mosquitoes, which exhibit no fitness cost, inserted into a predicted odorant receptor. 
Odorant receptors form a large family of genes that bind odorants and are used in host-
seeking and other olfaction-based orientation (Hallem et al. 2006). The insertion of the 
Rel2 cassette into this gene might, therefore, be expected to cause an inability of the 
mosquitoes to find hosts or oviposition sites, or interfere with similar olfaction-based 
activities. However, we did not observe any fitness cost of this insertion. This might be 
due to a number of factors. First, odorant receptors form a large family of genes, and 
there may be redundancy among them (Fox et al. 2001, Fox et al. 2002). Therefore, this 
gene may not be truly necessary, and interruption of it may not have an effect. 
Alternatively, because these mosquitoes are kept in small cages and provided both bloods 
and oviposition cups at very short range it is not necessary for long-range location of 
hosts or good breeding sites. We may have missed a fitness cost in these mosquitoes due 
to this short range, and such a cost would only be noticed in large cage or open-field trials 
where long-range seeking is necessary. 
 
3.3.4 Cage population competition experiments 
 Because we saw no major fitness effects at either the lifespan or fecundity level of 
the genetically modified mosquitoes, we next decided to determine the competitiveness 
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of the genetically modified mosquitoes against their wild-type conspecifics in mixed cage 
populations. To do that, we crossed 50 genetically modified stage 2 larvae with 50 wild-
type stage 2 larvae, allowed them to eclose, breed, take a blood meal and oviposit, then 
determined the proportion of the offspring that were genetically modified.  These 
experiments were performed both with normal sugar fed mosquitoes and mosquitoes fed 
on sugar containing antibiotics to clear their midgut microbiota.  Three of the five 
normal, septic, genetically modified strains showed the 75% genetically modified 
proportion of the population that would be expected under standard Hardy-Weinberg 
equilibrium (Figure 3.7A). However, both the DsPfs3 and CP15 lines exhibited increased 
numbers of genetically modified mosquitoes, with approximately 90% of the offspring 
being genetically modified. In mosquitoes treated with antibiotics, this effect disappeared 
and experiment using equal numbers of virgin male and female genetically modified or 
wild-type mosquitoes (Figure 3.7B).  This yielded the same result, indicating that it was 
not an artifact due to different mosquito populations.   
 We next investigated whether this effect was limited to the first generation of 
mosquitoes or whether the proportion of genetically modified mosquitoes would either 
decrease or increase over multiple generations. To do this, we performed a cross using 50 
genetically modified and 50 wild-type larvae again, but this time maintained the 
population for 10 generations. For each generation the larvae were screened to determine 
the proportion genetically modified, and only 100 larvae were kept, in order to maintain a 
constant population size, one of the necessary assumption for Hardy-Weinberg 
equilibrium. The larvae kept for each generation were chosen at the same proportion 
genetically modified as the total population, i.e. if 75% of the total population were 
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Figure 3.7: Crosses between genetically modified and wild-type mosquitoes. Crosses 
between wild-type and genetically modified mosquitoes were set up by combining A) 
50:50 2nd instar wild-type:genetically modified larvae or B) 25:25:25:25 wild-type 
male:wild-type female:genetically modified male:genetically modified female virgin 
adults. The adult mosquitoes were maintained on 10% sucrose (small hatches) or 10% 
sucrose with antibiotics to remove the midgut microbiota (large checks), and the percent 
of genetically modified larvae from the f1 generation were recorded. Under both cross 
conditions, CP15 and DsPfs3 strain mosquitoes have higher than expected GM numbers 
in the f1 generation when containing the natural microbiota. Mosquitoes of the C) CP15 
an D) DsPfs3 strains were maintained for 10 generations, showing that the increased 
proportion of genetically modified mosquitoes continues through multiple generations. At 
the 10
th
 generation, the resistance of the resultant genetically modified mosquitoes were 
tested for resistance to P. falciparum and are still highly refractory to the parasite for both 
strains (E, F), when compared using a Kruskall-Wallis test followed by a Dunn’s post-
hoc test using a=0.05 and * indicates a significant difference in the number of oocysts per 





WT WT from 
Cross
CP15
N 30 12 52
Range 0-29 0-25 0-13
Prevalence 96.67% 83.33% 48.07%
Fisher's test p -
value
0.1916 0.0001
Median 13 11 0




WT WT from 
Cross
DsPfs3
N 30 14 43
Range 1-28 0-23 0-10
Prevalence 100.00% 78.57% 53.48%
Fisher's test p -
value
0.0275 0.0001
Median 12.5 14 1







Table 3.2: Supplementary data for Figure 3.7. Includes the number of mosquitoes 
assayed, the range, prevalence, median and % change in the number of oocysts per 
mosquito midgut. 
 
genetically modified, 75% of the population maintained to the next generation were also 
genetically modified. After 10 generations, the proportion of mosquitoes bearing the 
genetic modification had not changed (Figure 3.7C, D).  At the 10th generation we 
investigated whether the genetically modified mosquitoes were still resistant to P. 
falciparum infection, and observed that mosquitoes bearing the genetic modification were 
more resistant to P. falciparum infection than wild-type mosquitoes, whether from the 
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original wild-type population or the remaining 10% wild-type mosquitoes from the 
crosses (Figure 3.7E, F). This indicates that these mosquitoes may be ready for larger 
scale trials, as we observed that our mosquitoes were able to compete well with their 
wild-type conspecifics, and that doing so does not compromise their resistance to 
infection.  
 While this observation needs to be confirmed in large-scale cage or field trials, 
our results indicate that the genetically modified mosquitoes may be able to compete with 
and replace wild-type mosquito populations, and therefore be useful for malaria control.  
However, we cannot be certain that the two genetically modified strains that have a 
greater invasion than expected by Hardy-Weinberg equilibrium will do the same in the 
field. We observed that this effect is highly dependent on the mosquito microbiota, which 
will depend greatly on the environmental conditions under which the mosquitoes are 
reared. In the laboratory the microbiota is much more consistent than in the field, so these 
effects may not carry through to larger populations.  
 We also measured the proportion of wild-type female mosquitoes inseminated by 
wild-type or genetically modified male mosquitoes in competition trials. Female 
mosquitoes were allowed to mate with equal numbers of wild-type and genetically 
modified male mosquitoes, allowing them to choose their mates. These experiments were 
carried out with or without antibiotic treatment to remove the native microbiota. There 
was no significant difference in the percent of mosquitoes inseminated by genetically 
modified males between the strains of mosquitoes (figure 3.8). Nor was there a difference 
in the number of eggs laid by mosquitoes inseminated by genetically modified or wild-




Figure 3.8: The insemination rate of wild-type females by wild-type or genetically 
modified males.  Equal numbers of virgin wild-type and genetically modified males 
were allowed to mate with virgin wild-type females, and the proportion inseminated by 
genetically modified or wild-type males was recorded. There was no difference in the 
proportion of females inseminated between the groups, whether or not the mosquitoes 
were maintained on normal sucrose solution or sucrose solution containing antibiotics to 
remove the midgut microflora. 
  
relationship between the midgut microbiota and mating has not been investigated in depth 
(Cator et al. 2009, Sanford et al. 2011). Further studies in this area, both with genetically 
modified mosquitoes and wild-type mosquitoes, are necessary to understand what might 
be causing these effects, and it is important to do so before releasing any genetically 
modified mosquitoes as part of a malaria control program, as mating dynamics will play a 
large role in the success of any population replacement program.  
 
3.3.5 Control of the midgut microbiota 
 In order to determine whether genetically modified mosquitoes differ in their gut 
microbiota, we used colony forming unit (CFU) assays to measure the number of 
culturable bacteria found in mosquito midguts both before and after a blood meal, to 





Figure 3.9: The number of culturable bacteria in genetically modified mosquito 
midguts. The number of culturable bacteria in adult female mosquito midguts was 
measured via colony forming unit assay in A) sugar fed females or B) blood fed females 
2 days post blood meal. Under both feeding conditions, CP15 and DsPfs3 females have 
significantly fewer culturable bacteria in their midguts than wild-type females. Both 
graphs represent pooled data from 10 individual mosquitoes from 3 generations 
compared by a Kruskal-Wallis test followed by a Dunn’s post-hoc test using a=0.05 and 
* indicates a significant difference in the number of culturable bacteria per midgut 
compared to wild-type mosquitoes. 
 
 
both timepoints, we observed no significant difference in the number of culturable 
bacteria in the mosquito midgut in three of the strains, but the CP15 and DsPfs3 strains 
had significantly fewer culturable bacteria in their midguts than wild-type mosquitoes 
contained. This effect may be due to both where the transgene is expressed in the 
mosquito and how general the effect of the inserted gene is. Genes expressed in the 
midgut, including in all strains other than the VG1 line, are in position to affect microbes 
in the midgut. Genes expressed in the fat body may not be able to interact with the 
midgut microbiota, and therefore may not affect the number of bacteria found therein.  
This would explain why the CP15 line is able to reduce the number of culturable bacteria, 
while the VG1 line is not. Likewise, the effector molecule expressed by genetically  




Figure 3.10: Resistance of genetically modified mosquitoes to multiple P. falciparum 
strains. Adult female mosquitoes were fed on infectious blood meals containing 
gametocytes from the A) Kenyan HL1204 and B) Brazilian 7g8 P. falciparum strains. All 
genetically modified mosquito strains tested exhibited increased resistance to both P. 
falciparum strains, indicating that these mosquitoes resist P. falciparum from multiple, 
geographically divergent, areas.  Each figure represents mosquitoes compared by a 
Kruskal-Wallis test followed by a Dunn’s post-hoc test using a=0.05, and * indicates a 
significant difference in the number of oocysts per midgut compared to wild-type 
mosquitoes. Additional data given in table 3.3 
 
modified lines may be too specific to affect both bacteria and Plasmodium. Some of the 
many genes with expression altered by Rel2 in the CP15 lines also have activity against 
bacteria, allowing this line to control the number of bacteria in their midguts. Conversely, 
the DSCAM spliceform exhibited by the DsPfL8 line may bind too specifically to P. 
falciparum to be able to bind to off-target organisms such as the gut microbiota, while the 
short form of DSCAM found in the DsPfs3 line may have a broader specificity, leading 
to the reduction in the culturable bacteria in these mosquitoes’ midguts..  This shows that 
the different genetically modified mosquito lines may have varied abilities to control their 
midgut microflora. As shown above, the mosquito microflora appears to influence 
mosquito reproductive patterns, while previous research has shown that the microflora  




WT CP15 VG1 DsPfs3 DsPfs11 DsPfL8
N 15 15 15 15 15 15
Range 0-15 0-3 0-4 0-4 0-4 0-4
Prevalence 73.33% 33.33% 26.67% 26.67% 20.00% 40.00%
Fisher's test 
p -value
0.0656 0.0268 0.0268 0.0092 0.1394
Median 6 0 0 0 0 0
% change 0.00% 0.00% 0.00% 0.00% 0.00%
Median no 
zeroes
10 2 3.5 2 2 2.5
WT CP15 VG1 DsPfs3 DsPfs11 DsPfL8
N 43 29 19 38 17 27
Range 0-17 0-2 0-2 0-3 0-3 0-5
Prevalence 66.67% 27.59% 36.84% 39.47% 41.47% 33.33%
Fisher's test 
p -value
0.0001 0.0092 0.0018 0.0333 0.0011
Median 2 0 0 0 0 0
% change 0.00% 0.00% 0.00% 0.00% 0.00%
Median no 
zeroes




Table 3.3: Supplementary data for Figure 3.10. Includes the number of mosquitoes 
assayed, the range, prevalence, median and % change in the number of oocysts per 
mosquito midgut. 
 
has a profound influence on mosquito resistance to P. falciparum and other pathogens 
(Dong et al. 2009). These reductions in the native microflora may be important for 
replacement of the wild-type population and control of the malaria parasite. 
 
3.3.6 Resistance to various P. falciparum strains 
 Because previous experiments on our genetically modified mosquitoes only 
considered resistance to the NF54 line of P. falciparum, while there is considerable 
variation in P. falciparum strains worldwide, we decided to test the resistance of these 
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genetically modified mosquitoes against multiple P. falciparum lines from widely 
distributed geographic areas.  We obtained two other strains of P. falciparum that would 
infect our mosquitoes, and tested the genetically modified strains for resistance to these.  
The genetically modified mosquitoes were highly resistant to both the Kenyan HL1204 
and the Brazilian 7g8 strains, indicating that the mosquitoes can resist multiple strains of 
P. falciparum (Figure 3.9) (van Schalkwyk et al. 2013). While other laboratories have 
shown that the geographic distribution of both the mosquito and the parasite relative to 
each other, we have shown that our mosquitoes are able to resist infections from different 
areas (Molina-Cruz and Barillas-Mury 2014). While parasites from a given area may be 
able to evade the immune response in mosquitoes from other areas, they are not able to 
do so in our genetically modified mosquitoes. This is likely due to the large upregulation 
of the targeted genes, which may overwhelm the evasion of the parasites. Again, this 
indicates that these genetically modified mosquitoes may be a viable tool for malaria 
control, as the same effector mechanism could be used in multiple areas. Though 
different mosquito species would have to be modified for different geographic areas, the 
genes upregulated in our mosquitoes could be used in multiple areas, making the 
mosquitoes easier to create and the intervention easier to implement.  
 
3.3.7 Resistance to O’nyong’nyong virus 
 Anopheles mosquitoes also act as the vector for the O'nyong'nyong virus, which 
causes a fever and symptoms similar to dengue fever. This virus has been spreading in 
recent years, and may continue to do so (Powers et al. 2000). Therefore, if genetically 




Figure 3.11: Resistance of genetically modified mosquitoes to ONNV. Adult female 
mosquitoes were provided an infectious blood meal containing O’nyong’nyong virus. 
Genetically modified mosquitoes showed no difference from wild-type mosquitoes in 
their ability to be infected with ONNV.  This figure represents 10 mosquitoes from each 
of 3 generations compared by a Kruskal-Wallis test and a=0.05. 
 
 
to spread this virus any better than wild-type mosquitoes. It is also possible that the 
genetically modified mosquitoes would resist this virus, making them an even more 
effective vector-borne disease control tool.  To that end, we tested the ability of our 
mosquitoes to be infected by ONNV. All past studies on ONNV in mosquitoes have been 
performed in An. gambiae, but initial tests in our lab showed that An. stephensi 
mosquitoes can also be infected with the virus, albeit at a Lower rate (data not shown).  
Our genetically modified mosquitoes showed no difference in their ability to be infected 
with ONNV compared to wild-type mosquitoes (Figure 3.10). Past studies have not 
looked into the manner in which An. gambiae mosquitoes react to or resist ONNV 
infection, so we do not know the mechanism of resistance.  However, other alphaviruses, 
such as dengue virus, are controlled largely by the Toll, JAK/STAT and RNAi pathways 
(Xi et al. 2008a, Souza-Neto et al. 2009, Jupatanakul et al. 2013). Our mosquitoes have 
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alterations to their IMD pathway or a specific immune gene, and therefore it is unlikely 
that they would be resistant to viruses.  
 
3.3.8 Resistance to insecticides 
 If a wild-type mosquito population were replaced by a refractory population, the 
mosquitoes would still act as a nuisance to people. Therefore, people would still want to 
be able to remove or avoid being bitten by the mosquitoes as needed, so the mosquitoes 
would need to continue to be susceptible to insecticides. To ensure that this is the case, 
we tested the susceptibility of our mosquito strains to various insecticides from different  
classes. We chose to test the mosquitoes with the pyrethroid permethrin, the 
organophosphate malathion, the carbamate bendiocarb and the organochloride 
dichlorodiphenyltrichloroethane (DDT) using a standard WHO assay based on insecticide 
impregnated papers. Both 1 and 24 hours after exposure to the insecticides all mosquitoes 
were knocked down, while only a small proportion of the control mosquitoes were 
knocked down, indicating that the genetically modified mosquitoes are just as susceptible 
to insecticides as the wild-type mosquitoes. The fact that these mosquitoes are highly 
sensitive to insecticides, and that the genetic modifications do not increase their 
resistance to them would allow the mosquitoes to be removed from the field if necessary,  
as well as allowing these mosquitoes to be used in areas currently employing long lasting 
insecticide treated bednets or indoor residual spraying. These currently implemented 
vector control methods would not need to be stopped, nor would they lose effectiveness 
after these genetically modified mosquitoes were released, which would likely aid in 




Figure 3.12: Resistance of genetically modified mosquitoes to insecticides. Blood fed 
adult female mosquitoes were exposed to various insecticides for 1 hour immediately 
following a blood meal, and their survival was recorded A) 1 or B) 24 hours post 
exposure. Genetically modified mosquitoes showed no difference from wild-type 
mosquitoes in their resistance to various insecticides. Figures represents 25 mosquitoes 
from each of 3 generations. 
 
3.3.9 Compatibility with Wolbachia infection 
 Another intervention that has been suggested to control vector-borne diseases is 
the use of the intracellular bacteria Wolbachia. This bacteria is a reproductive parasite 
which uses modification of its host reproductive system to quickly spread to fixation in a 
population (Sinkins 2004). While not naturally found in many common disease vectors, 
such as Aedes aegypti or Anopheles spp. mosquitoes in general, it is found in 
approximately 75% of insect species and numerous other arthropods, showing different 
reproductive phenotypes depending on its host (Jeyaprakash and Hoy 2000). Due to its 
ability to spread in a population, this bacteria was initially suggested as a gene driver to 
spread a genetically modified mosquito population into a wild-type population (Sinkins 
and Godfray 2004). However, later experiments showed that infection with Wolbachia 
can act as an anti-parasite effector by itself, as it reduces infection with various 
pathogens, including P. falciparum and multiple viruses (Hedges et al. 2008, Bian et al. 
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2010, Bian et al. 2013).  Therefore, Wolbachia is now being considered as a standalone 
disease intervention, and Wolbachia infected Ae. aegypti are being deployed to combat 
dengue virus in numerous locations around the world (Hoffmann et al. 2011). While 
Anopheles spp. mosquitoes have only recently been infected with Wolbachia and are still 
far from being used to fight Plasmodium infections, they do show significantly reduced 
infection with P. falciparum (Hughes et al. 2011, Bian et al. 2013). These Wolbachia 
infected Anopheles mosquitoes may one day be used to control malaria, as may 
genetically modified mosquitoes. If this is the case, the two cannot be incompatible, as 
their distributions may overlap. Likewise, the two interventions could be combined to 
increase their resistance to infection or utilize Wolbachia as a gene driver for the 
genetically modified mosquitoes. However, Wolbachia are gram negative bacteria, which 
are generally controlled by the IMD pathway. Therefore, our genetically modified 
mosquitoes may affect Wolbachia infection levels. Wolbachia densities have been shown 
to correlate with the effectiveness of the reproductive modifications caused by 
Wolbachia, so a decrease in bacterial densities could limit the effectiveness of the 
intervention (Mouton et al. 2006, Duron et al. 2007). 
 We tested the Plasmodium resistance of crosses between genetically modified and 
Wolbachia infected mosquitoes. By crossing virgin Wolbachia infected female 
mosquitoes with virgin genetically modified male mosquitoes, we created genetically 
modified mosquitoes that were simultaneously infected with Wolbachia. Females of the 
f1 generation were tested for their resistance to P. falciparum infection, and we saw no 
difference in the ability of Wolbachia infected genetically modified mosquitoes to resist 




Figure 3.13: Resistance of genetically modified mosquitoes to P. falciparum after 
crossing with Wolbachia infected lines. Genetically modified mosquitoes were crossed 
with Wolbachia infected mosquitoes to create lines that were both genetically modified 
and Wolbachia infected and provided a P. falciparum infectious blood meal at a A) low 
infection level or B) high infection level.  All lines had fewer oocysts on their midguts 
than wild-type mosquitoes when infected at a high level, but mosquitoes bearing both the 
genetic modification and the Wolbachia infection did not differ in their P. falciparum 
resistance from genetically modified or Wolbachia infected mosquitoes alone, regardless 
of infection level.  Strains were compared using a Kruskal-Wallis test and Dunn’s post-
hoc test with a=0.05, and * indicates a significant difference in the number of oocysts per 
midgut compared to wild-type mosquitoes. Additional data in table 3.4. 
 
We initially tested infection at a low level, to mimic the low levels of oocysts found in 
mosquitoes in nature. However, this low level of infection may be so low as to mask any 
additional decrease in infection when the two lines are crossed. Therefore, we repeated 
the experiment with a higher level of infectious parasites in the blood meal, but saw the 
same result. This indicates that there is no additive effect to combining the two 
interventions, but likewise that there is no negative effect to combining them. Therefore, 
the two interventions could be deployed in the same geographic area without hindering 
resistance to P. falciparum. As with insecticide susceptibility, the compatibility of  
genetically modified mosquitoes with Wolbachia infected mosquitoes could be important 
for the control of P. falciparum. 




WT CP15 CP15 x 
LB1
LB1 DsPfs3 x 
LB1
DsPfs3
N 21 22 19 12 14 21
Range 0-3 0-2 0-4 0-3 0-3 0-4
Prevalence 57.14% 40.90% 42.10% 41.67% 42.86% 47.62%
Fisher's test p -
value
0.366 0.5273 0.4813 0.4998 0.7579
Median 1 0 0 0 0 0
% change 0.00% 0.00% 0.00% 0.00% 0.00%
Median no 
zeroes
1 1 2 1 1 2
WT CP15 CP15 x 
LB1
LB1 DsPfs3 x 
LB1
DsPfs3
N 28 26 30 27 26 27
Range 0-31 0-24 0-21 0-27 0-20 0-21
Prevalence 9284.00% 84.62% 86.67% 85.19% 84.62% 85.19%
Fisher's test p -
value
0.4126 0.6714 0.4216 0.4126 0.4216
Median 18 4.5 6.5 8 6.5 7
% change 25.00% 36.11% 44.44% 36.11% 38.88%
Median no 
zeroes
19 6.5 7 10 7 7
Figure 3.13A
Figure 3.13B
 Table 3.3: Supplementary data for Figure 3.10. Includes the number of mosquitoes 
assayed, the range, prevalence, median and % change in the number of oocysts per 
mosquito midgut. 
 
3.4 Conclusions  
While many people have assumed that there will be a fitness cost associated with 
any genetic modification, and that this will interfere with the ability of genetically 
modified mosquitoes to be used for malaria control, we did not find evidence of this 
under laboratory insectary conditions. We tested five separate genetically modified 
mosquito lines and only found evidence for decreased fitness in one line. When 
considering mosquito lifespan, size, fecundity and many other variables there was only a 
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fitness cost in one strain, which can be explained as a position effect. In the one case with 
a fitness effect, the construct inserted just 3' of a gene, and the same construct inserted 
into a different location experienced no noticeable effect.  Together, this indicates that 
there is no inherent cost to genetic modification in mosquitoes, though some strains may 
experience one. While these studies are limited to laboratory experiments, there is 
nothing to indicate that the mosquitoes should not be used in larger scale cage or field 
experiments, and there is no reason to believe that these mosquitoes would not be able to 
form an important part of malaria control programs in the future. However, these tests 
were all performed under standard laboratory conditions, and not all findings presented 
herein may apply under field conditions. Conditions such as fluctuating temperatures, 
host seeking and the large spatial scale present in the field may exacerbate or expose 
unobserved fitness effects. Also, while our mosquitoes appear fit, either a genetic drive 
mechanism or a reduction in the wild-type population followed by inundative releases 
would be necessary to drive the genetically modified mosquitoes to fixation. Similarly, 
for any genetically modified organism to be distributed on a large scale requires both 
governmental and popular support, and may encounter resistance. Finally, these 
mosquitoes are not fully resistant to P. falciparum infection, and greater resistance should 
be sought before these mosquitoes are employed as part of a large scale malaria control 
program. Despite these limitations thus far, genetically modified mosquitoes show no 
inherent fitness costs and further work should be done to improve their effectiveness. 
Similarly, large-scale field trials should be performed to determine how these mosquitoes 
perform on a large spatial scale. This will allow us to evaluate the effectiveness of these 
mosquitoes to control malaria, and allow us to make informed decisions about their use. 
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The data presented in this study indicate that genetically modified mosquitoes are a 
viable tool for malaria control programs.  
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Chapter 4: Conclusions and future directions 
 The recent availability of the An. gambiae and An. stephensi genomes have 
allowed great leaps in the knowledge of these two vector species and their interactions 
with the human malaria parasite. This genomic information has allowed researchers to 
determine the important mosquito immune pathways responsible for resistance to the 
Plasmodium spp. parasites responsible for malaria in humans. Further, this knowledge, 
combined with recent advances in the genetic engineering of mosquitoes, has led to the 
ability of multiple laboratories to create genetically modified mosquitoes with increased 
resistance to Plasmodium infection. Our lab is one that has created P. falciparum 
refractory mosquitoes, though these mosquitoes have not yet been deployed in the field. 
 We used two P. falciparum resistant An. stephensi lines that over-express the Rel2 
associated transcription factor Rel2 upon taking a blood meal to elucidate the genes under 
the control of the IMD immune pathway in An. stephensi mosquitoes. The IMD pathway 
is one of the main immune pathways responsible for mosquito resistance to gram-
negative bacteria and P. falciparum, and is a good target for creating mosquitoes resistant 
to the human malaria parasite. By studying the global transcriptomic and proteomic 
effects of Rel2 overexpression we have identified a large number of genes under the 
control of Rel2. Examining these genes further has shown that a large number of genes 
both within and outside the canonical immune pathways are controlled by Rel2, 
indicating that this transcription factor has wide-ranging effects on mosquito gene 
control. Further, we were able to identify numerous novel mosquito genes responsible for 
resistance to the human malaria parasite. 
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 While many genetically modified mosquito strains resistant to P. falciparum 
infection have been created by a variety of labs, none have been employed as a part of a 
widespread malaria control program. While a variety of factors influence this lack of 
implementation, one major contributing factor is that people often assume that genetically 
modified organisms will carry an inherent fitness cost. We tested 5 separate genetically 
modified mosquito lines under a variety of conditions and observed no fitness cost in 4 of 
the lines. The 5
th
 line, which did bear a fitness cost, showed that the gene cassette inserted 
near another gene, indicating that the fitness effects were due to a position effect, and not 
the act of genetic modification itself, as an identical copy of the same insert at a different 
location in another line did not impose a fitness cost. Furthermore, all tested mosquitoes 
were resistant to various P. falciparum strains, but showed no increased resistance to 
other pathogens or insecticides, nor any negative interactions with the bacterium 
Wolbachia. This indicates that genetically modified mosquitoes can form a part of future 
malaria control programs without large negative effects. While all experiments were 
performed in laboratory settings, there is no evidence that further tests on these lines, 
including larger cage and field trials should not be pursued. Because there was no fitness 
effect in the laboratory shows that these genetically modified mosquito strains are ready 
for much larger-scale trials and, potentially, implementation as part of a malaria control 
program. 
 However, much work remains to be done before these mosquitoes can be 
deployed in the field. Notably, the fact that all these tests were done in the laboratory 
means that there may be unforeseen effects of genetic modification in the field. While 
most of our strains had no negative fitness effects in the laboratory, the large number of 
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differentially-regulated genes in the Rel2 mosquitoes indicates that there is a large energy 
expenditure associated with the genetic modifications, and that a fitness effect is possible. 
These effects may not be noticed until deployment in the field, and therefore field trials 
are important prior to large scale releases. 
 Even if these mosquitoes are completely successful in the field, there are still 
many barriers between genetically modified mosquito releases and full malaria 
eradication. For example, these mosquitoes are not fully resistant to Plasmodium 
infection. Models indicate that in areas with high levels of malaria transmission full 
resistance and full replacement are necessary for control. Therefore, mosquitoes with 
greater resistance must be developed. Similarly, mosquitoes with an adequate gene driver 
or strategies for gene driver-independent releases are necessary to allow the refractory 
genetically modified mosquitoes to replace the wild-type mosquitoes. Before any release 
of genetically modified organisms can proceed, public support of the release must be 
gathered. While there have been some releases of genetically modified insects and other 
organisms, widespread acceptance of genetic modification has not yet occurred, and this 
remains an area ready for research and policy-based advances. There are also other 
pathogens spread by Anopheles mosquitoes, such as Wuchereria bancrofti against which 
these mosquitoes should be tested. Finally, any release will require a facility to rear a 
large number of mosquitoes to be released. Recent advances in mosquito rearing and 
screening have made progress toward this goal, but are not yet ready for full 
implementation. Generally, therefore, while genetically modified mosquitoes are ready 
for the next step toward implementation, they must be tested on a small scale before 
being released and any intervention must be slowly scaled up. 
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 We have shown that, despite the great increase in global gene transcription and 
translation in genetically modified mosquitoes, there is no reason to believe that genetic 
modification of mosquitoes based on transient expression of the gene of interest 
following a blood meal will lead to a fitness detriment. Our mosquitoes showed negative 
fitness costs only when the gene integrated near another gene, a condition that is easy to 
detect. This means that any genetically modified mosquitoes meant for vector-borne 
disease control should be screened for these effects, but that they are not inherent to the 
system. Therefore, genetically modified mosquitoes remain a viable tool for malaria 
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